<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.2 20190208//EN" "JATS-archivearticle1-mathml3.dtd"> 
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="review-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName journalpublishing.dtd?><?SourceDTD.Version 2.3?><?ConverterInfo.XSLTName jp2nlmx2.xsl?><?ConverterInfo.Version 1?><front><journal-meta><journal-id journal-id-type="nlm-ta">Front Microbiol</journal-id><journal-id journal-id-type="iso-abbrev">Front Microbiol</journal-id><journal-id journal-id-type="publisher-id">Front. Microbiol.</journal-id><journal-title-group><journal-title>Frontiers in Microbiology</journal-title></journal-title-group><issn pub-type="epub">1664-302X</issn><publisher><publisher-name>Frontiers Media S.A.</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">7325946</article-id><article-id pub-id-type="doi">10.3389/fmicb.2020.01173</article-id><article-categories><subj-group subj-group-type="heading"><subject>Microbiology</subject><subj-group><subject>Mini Review</subject></subj-group></subj-group></article-categories><title-group><article-title>Glycopeptide Antibiotic Resistance Genes: Distribution and Function in the Producer Actinomycetes</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Yushchuk</surname><given-names>Oleksandr</given-names></name><xref rid="fn1" ref-type="author-notes"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/851585/overview"/></contrib><contrib contrib-type="author"><name><surname>Binda</surname><given-names>Elisa</given-names></name><xref rid="fn1" ref-type="author-notes"><sup>&#x02020;</sup></xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/314856/overview"/></contrib><contrib contrib-type="author"><name><surname>Marinelli</surname><given-names>Flavia</given-names></name><xref rid="c001" ref-type="corresp"><sup>*</sup></xref><uri xlink:type="simple" xlink:href="https://loop.frontiersin.org/people/319577/overview"/></contrib></contrib-group><aff><institution>Department of Biotechnology and Life Sciences, University of Insubria</institution>, <addr-line>Varese</addr-line>, <country>Italy</country></aff><author-notes><fn id="fn2" fn-type="edited-by"><p>Edited by: Jose L. Martinez, Consejo Superior de Investigaciones Cient&#x000ed;ficas (CSIC), Spain</p></fn><fn id="fn3" fn-type="edited-by"><p>Reviewed by: Kapil Tahlan, Memorial University of Newfoundland, Canada</p><p>Sonia Gull&#x000f3;n, Centro Nacional de Biotecnolog&#x000ed;a (CNB), Spain</p></fn><fn id="fn1" fn-type="equal"><p><sup>&#x02020;</sup>These authors have contributed equally to this work</p></fn><fn id="fn4" fn-type="other"><p>This article was submitted to Antimicrobials, Resistance and Chemotherapy, a section of the journal Frontiers in Microbiology</p></fn><corresp id="c001">*Correspondence: Flavia Marinelli, <email>flavia.marinelli@uninsubria.it</email></corresp></author-notes><pub-date pub-type="epub"><day>17</day><month>6</month><year>2020</year></pub-date><pub-date pub-type="collection"><year>2020</year></pub-date><volume>11</volume><elocation-id>1173</elocation-id><history><date date-type="received"><day>14</day><month>2</month><year>2020</year></date><date date-type="accepted"><day>07</day><month>5</month><year>2020</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2020 Yushchuk, Binda and Marinelli.</copyright-statement><copyright-year>2020</copyright-year><copyright-holder>Yushchuk, Binda and Marinelli</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</license-p></license></permissions><abstract><p>Glycopeptide antibiotics (GPAs) are considered drugs of &#x0201c;last resort&#x0201d; for the treatment of life-threatening infections caused by relevant Gram-positive pathogens (enterococci, staphylococci, and clostridia). Driven by the issue of the never-stopping evolution of bacterial antibiotic resistance, research on GPA biosynthesis and resistance is developing fast in modern &#x0201c;post-genomic&#x0201d; era. It is today widely accepted that resistance mechanisms emerging in pathogens have been acquired from the soil-dwelling antibiotic-producing actinomycetes, which use them to avoid suicide during production, rather than being orchestrated <italic>de novo</italic> by pathogen bacteria upon continued treatment. Actually, more and more genomes of GPA producers are being unraveled, carrying a broad collection of differently arranged GPA resistance (named <italic>van</italic>) genes. In the producer actinomycetes, <italic>van</italic> genes are generally associated with the antibiotic biosynthetic gene clusters (BGCs) deputed to GPA biosynthesis, being probably transferred/arranged together, favoring a possible co-regulation between antibiotic production and self-resistance. GPA BGC-associated <italic>van</italic> genes have been also found mining public databases of bacterial genomic and metagenomic sequences. Interestingly, some BGCs for antibiotics, seemingly unrelated to GPAs (e.g., feglymycin), carry <italic>van</italic> gene homologues. Herein, we would like to cover the recent advances on the distribution of GPA resistance genes in genomic and metagenomics datasets related to GPA potential/proved producer microorganisms. A thorough understanding of GPA resistance in the producing microorganisms may prove useful in the future surveillance of emerging mechanisms of resistance to this clinically relevant antibiotic class.</p></abstract><kwd-group><kwd>antimicrobial resistance</kwd><kwd>glycopeptide antibiotics</kwd><kwd><italic>van</italic> genes</kwd><kwd>glycopeptide producers</kwd><kwd>biosynthetic gene clusters</kwd></kwd-group><funding-group><award-group><funding-source id="cn1">Fondo di Ateneo per la Ricerca</funding-source></award-group><award-group><funding-source id="cn2">Consorzio Italbiotec</funding-source></award-group></funding-group><counts><fig-count count="2"/><table-count count="0"/><equation-count count="0"/><ref-count count="92"/><page-count count="9"/><word-count count="7188"/></counts></article-meta></front><body><sec sec-type="intro" id="sec2"><title>Gpa Mode of Action and Resistance Genes in Gram-Positive Pathogens</title><p>According to a recent report (<xref rid="ref83" ref-type="bibr">WHO, 2017</xref>), drug-resistant infections will kill more people than cancer in just over three decades: by 2050, 10 million people are going to die every year due to antimicrobial resistance (AMR). Consequently, it is mandatory to stimulate discovery and development of novel antibiotics to counteract AMR (<xref rid="ref60" ref-type="bibr">O&#x02019;Neill, 2016</xref>). Glycopeptide antibiotics (GPAs) are frequently used to treat life-threatening infections caused by multidrug-resistant Gram-positive pathogens, such as <italic>Staphylococcus aureus</italic>, <italic>Enterococcus</italic> spp., and <italic>Clostridium difficile</italic> (for a review on their discovery and development, see <xref rid="ref49" ref-type="bibr">Marcone et al., 2018</xref>; on their antimicrobial activity and clinical use, <xref rid="ref92" ref-type="bibr">Zeng et al., 2016</xref>). GPAs inhibit bacterial cell wall synthesis in Gram-positive bacteria by binding to <sc>d</sc>-alanyl-<sc>d</sc>-alanine (<sc>d</sc>-Ala-<sc>d</sc>-Ala) dipeptide terminus of peptidoglycan (PG) precursors, sequestering the substrate from transpeptidation and transglycosylation reactions in the late extracellular stages of PG cross-linking. Thus, GPA action ultimately results in destabilizing cell wall integrity, causing bacterial cell death (<xref rid="ref63" ref-type="bibr">Perkins and Nieto, 1974</xref>). Gram-negative microorganisms are intrinsically resistant to GPAs, because of their outer membrane, which prevents these molecules entering into the periplasm. In Gram-positive bacteria, the onset of vancomycin resistance was long-delayed in comparison to other antibiotic classes. The first vancomycin-resistant clinical isolate &#x02013; an <italic>Enterococcus faecium</italic> strain &#x02013; was reported in 1987, more than 30 years after the clinical introduction of vancomycin (<xref rid="ref45" ref-type="bibr">Leclercq et al., 1988</xref>, <xref rid="ref54" ref-type="bibr">Miller et al., 2016</xref>). Unfortunately, today a vast majority of <italic>E. faecium</italic> isolates harbor vancomycin resistance genes (<italic>van</italic>) (<xref rid="ref80" ref-type="bibr">Vehreschild et al., 2019</xref>). The first vancomycin-resistant <italic>S. aureus</italic> (VRSA) isolate was reported in 2002 as a result of horizontal gene transfer from resistant enterococci (<xref rid="ref14" ref-type="bibr">Bartley, 2002</xref>; <xref rid="ref82" ref-type="bibr">Weigel et al., 2003</xref>); nowadays, 52 VRSA strains have been described worldwide (<xref rid="ref25" ref-type="bibr">Cong et al., 2020</xref>).</p><p>The GPA resistance mechanisms in Gram-positive pathogens were intensively studied starting from the pioneering work published in the 1990s (<xref rid="ref9" ref-type="bibr">Arthur et al., 1992</xref>, <xref rid="ref8" ref-type="bibr">1996</xref>). Gram-positive pathogens escape GPA action by reprogramming PG precursor biosynthesis, replacing the terminal <sc>d</sc>-Ala with <sc>d</sc>-lactate (<sc>d</sc>-Ala-<sc>d</sc>-Lac) or <sc>d</sc>-serine (<sc>d</sc>-Ala-<sc>d</sc>-Ser), thus reducing the affinity for cellular targets (<xref rid="ref9" ref-type="bibr">Arthur et al., 1992</xref>, <xref rid="ref8" ref-type="bibr">1996</xref>; <xref rid="ref26" ref-type="bibr">Courvalin, 2006</xref>). In enterococci, many different GPA-resistant phenotypes have been described according to their <italic>van</italic> gene operon organization (for a review, see <xref rid="ref20" ref-type="bibr">Binda et al., 2014</xref>): in <italic>vanA</italic>, <italic>vanB</italic>, <italic>vanD</italic>, and <italic>vanM</italic> the key ligase determines the replacement of the terminus <sc>d</sc>-Ala with <sc>d</sc>-Lac, whereas in <italic>vanC</italic>, <italic>vanE</italic>, <italic>vanG</italic>, <italic>vanL</italic>, and <italic>vanN</italic>
<sc>d</sc>-Ala. The <sc>d</sc>-Ala-<sc>d</sc>-Lac-type operons are located either on plasmids or on chromosomes, whereas the <sc>d</sc>-Ala-<sc>d</sc>-Ser-type ones are exclusively on the bacterial chromosome, except the case of <italic>vanN</italic> found on a plasmid in <italic>E. faecium</italic>. Operon expression could be inducible by GPAs (<italic>vanA</italic>, <italic>vanB</italic>, <italic>vanG</italic>, <italic>vanE</italic>, <italic>vanL</italic>, and <italic>vanM</italic>) or constitutive (<italic>vanC</italic>, <italic>vanD</italic>, and <italic>vanN</italic>) (<xref rid="ref67" ref-type="bibr">Reynolds and Courvalin, 2005</xref>; <xref rid="ref28" ref-type="bibr">Depardieu et al., 2007</xref>; <xref rid="ref20" ref-type="bibr">Binda et al., 2014</xref>). The most clinically relevant manifestation of GPA resistance occurs in VanA enterococci and staphylococci, and in VanB enterococci. The first group is highly resistant to both vancomycin and teicoplanin, whereas the second group only to vancomycin. In both of them, resistance is mediated by the GPA-induced expression of the transposone-located <italic>vanHAX</italic> gene operon under the transcriptional control of the VanR/VanS two-component system (TCS). VanS is a membrane-associated sensor that in VanA bacteria is activated by the presence of either vancomycin or teicoplanin, whereas in VanB it is activated only by vancomycin. Consequently, VanB enterococci are sensitive to teicoplanin (<xref rid="ref7" ref-type="bibr">Arthur et al., 1997</xref>, <xref rid="ref5" ref-type="bibr">1999</xref>; <xref rid="ref4" ref-type="bibr">Arthur and Quintiliani, 2001</xref>). Activated VanS transfers a phosphoryl group to VanR, which is the response regulator that controls the co-transcription of the <italic>vanH</italic>, <italic>vanA</italic>, <italic>vanX</italic>, and <italic>vanY</italic> genes (<xref rid="ref85" ref-type="bibr">Wright et al., 1993</xref>; <xref rid="ref7" ref-type="bibr">Arthur et al., 1997</xref>, <xref rid="ref5" ref-type="bibr">1999</xref>; <xref rid="ref4" ref-type="bibr">Arthur and Quintilliani, 2001</xref>). VanH is a dehydrogenase that reduces pyruvate to <sc>d</sc>-lactate; VanA is the key ligase that catalyzes the formation of the <sc>d</sc>-Ala-<sc>d</sc>-Lac resistant depsipeptide (<xref rid="ref23" ref-type="bibr">Bugg et al., 1991</xref>; <xref rid="ref9" ref-type="bibr">Arthur et al., 1992</xref>); VanX is a <sc>d</sc>,<sc>d</sc>-dipeptidase, which removes the intracellular pool of <sc>d</sc>-Ala-<sc>d</sc>-Ala produced by the native enterococcal ligase, ensuring that <sc>d</sc>-Ala-<sc>d</sc>-Lac is incorporated into PG precursors (<xref rid="ref68" ref-type="bibr">Reynolds et al., 1994</xref>; <xref rid="ref86" ref-type="bibr">Wu et al., 1995</xref>); and finally VanY has an ancillary role as a <sc>d</sc>,<sc>d</sc>-carboxypeptidase cleaving the last <sc>d</sc>-Ala from the residual pentapeptide PG precursors terminating in <sc>d</sc>-Ala-<sc>d</sc>-Ala (<xref rid="ref6" ref-type="bibr">Arthur et al., 1998</xref>). Among the <sc>d</sc>-Ala-<sc>d</sc>-Ser-type operons, the better investigated was the <italic>vanC</italic>. It encodes for a racemase (VanT) that converts <sc>l</sc>-Ser to <sc>d</sc>-Ser, a ligase (VanC) that synthesizes <sc>d</sc>-Ala-<sc>d</sc>-Ser, and a bi-functional <sc>d</sc>,<sc>d</sc>-dipeptidase/<sc>d</sc>,<sc>d</sc>-carboxypeptidase (VanXYc) that cleaves the residual pools of <sc>d</sc>-Ala-<sc>d</sc>-Ala (<xref rid="ref18" ref-type="bibr">Billot-Klein et al., 1994</xref>; <xref rid="ref67" ref-type="bibr">Reynolds and Courvalin, 2005</xref>). In VanC phenotype, the TCS VanRcSc is located downstream the operon, but the resistance is constitutive due to mutations in the sensor VanSc (<xref rid="ref33" ref-type="bibr">Healy et al., 2000</xref>; <xref rid="ref34" ref-type="bibr">Hong et al., 2008</xref>; <xref rid="ref41" ref-type="bibr">Koteva et al., 2010</xref>). VanC enterococci are intrinsically resistant to low levels of vancomycin, although they remain sensitive to teicoplanin.</p><p>Additional variants of these <italic>van</italic> gene operons were found in other Gram-positive pathogens including <italic>Listeria</italic> spp., streptococci, clostridia (<xref rid="ref17" ref-type="bibr">Biavasco et al., 1996</xref>; <xref rid="ref66" ref-type="bibr">Poyart et al., 1997</xref>; <xref rid="ref62" ref-type="bibr">Peltier et al., 2013</xref>), and also in nonpathogenic Gram-positives, including <italic>Bacillus circulans</italic>, <italic>Oerskovia</italic> spp., <italic>Corynebacterium</italic> spp., and <italic>Streptomyces coelicolor</italic> (<xref rid="ref65" ref-type="bibr">Power et al., 1995</xref>; <xref rid="ref29" ref-type="bibr">Fontana et al., 1997</xref>; <xref rid="ref35" ref-type="bibr">Hong et al., 2004</xref>). A novel vancomycin <italic>vanF</italic> operon (<italic>vanY<sub>F</sub>Z<sub>F</sub>H<sub>F</sub>FX<sub>F</sub></italic>) was described in <italic>Paenibacillus popilliae</italic>, an environmental bacteria used as biopesticide to counteract beetle larvae that caused milky disease in Japan (<xref rid="ref61" ref-type="bibr">Patel et al., 2000</xref>; <xref rid="ref2" ref-type="bibr">Ahmed and Baptiste, 2018</xref>). The dissemination of GPA resistance more recently reached zoonotic pathogens such as the emergent <italic>Streptococcus suis</italic>, where the low level of vancomycin-resistance is due to the presence of a <italic>vanG</italic>-like operon (<xref rid="ref36" ref-type="bibr">Huang et al., 2018</xref>). Herein, we focus our attention on <italic>van</italic> genes distribution and function in the GPA-producing actinomycetes, which are considered the putative primary source of the variety of GPA-resistant determinants occurring in environmental bacteria and pathogens (<xref rid="ref53" ref-type="bibr">Marshall et al., 1998</xref>; <xref rid="ref15" ref-type="bibr">Beltrametti et al., 2007</xref>; <xref rid="ref51" ref-type="bibr">Marcone et al., 2010</xref>, <xref rid="ref50" ref-type="bibr">2014</xref>; <xref rid="ref70" ref-type="bibr">Sch&#x000e4;berle et al., 2011</xref>).</p></sec><sec id="sec3"><title>Updating The Glycopeptide Resistance Paradigm For The Gpa-Producing Strains: <italic>Van</italic> Genes And Their Organization In Known And Putative Gpa Bgcs</title><p>Actinomycetes are Gram-positive soil-dwelling bacteria, which produce about two-thirds of the naturally derived antibiotics with clinical use (<xref rid="ref16" ref-type="bibr">B&#x000e9;rdy, 2012</xref>; <xref rid="ref13" ref-type="bibr">Barka et al., 2015</xref>), including GPAs (<xref rid="ref58" ref-type="bibr">Nicolaou et al., 1999</xref>). Clinically relevant GPAs are produced by <italic>Amycolatopsis orientalis</italic> (vancomycin), <italic>Actinoplanes teichomyceticus</italic> (teicoplanin), and <italic>Nonomuraea gerenzanensis</italic> (dalbavancin precursor &#x02013; A40926) (<xref rid="ref92" ref-type="bibr">Zeng et al., 2016</xref>; <xref rid="ref49" ref-type="bibr">Marcone et al., 2018</xref>). GPA producers require self-resistance mechanisms to avoid suicide during antibiotic production and, like in pathogens, such resistance is due to <italic>van</italic> genes, whose description dates back to the end of the 1990s, one decade later than in pathogens (<xref rid="ref52" ref-type="bibr">Marshall et al., 1997</xref>, <xref rid="ref53" ref-type="bibr">1998</xref>). Sequence and operon structure similarities of <italic>van</italic> genes between pathogens and GPA-producers are significant (<xref rid="ref34" ref-type="bibr">Hong et al., 2008</xref>; <xref rid="ref20" ref-type="bibr">Binda et al., 2014</xref>). The intriguing aspect is that in GPA producers, <italic>van</italic> genes are usually located within the GPA biosynthetic gene clusters (BGCs) deputed to the antibiotic biosynthesis (<xref rid="ref64" ref-type="bibr">Pootoolal et al., 2002</xref>; <xref rid="ref15" ref-type="bibr">Beltrametti et al., 2007</xref>; <xref rid="ref51" ref-type="bibr">Marcone et al., 2010</xref>, <xref rid="ref50" ref-type="bibr">2014</xref>; <xref rid="ref70" ref-type="bibr">Sch&#x000e4;berle et al., 2011</xref>). In the last two decades, multiple novel GPA BGCs from actinomycetes were sequenced and annotated, and each of them (with few exceptions, see below) contains <italic>van</italic> genes (<xref rid="fig1" ref-type="fig">Figure 1</xref>).</p><fig id="fig1" position="float"><label>Figure 1(Continued)FIGURE 1</label><caption><p>Organization of <italic>van</italic> genes orthologues in glycopeptide antibiotic (GPA) biosynthetic gene clusters (BGCs) of producers and metagenomics sequences: (A) family <italic>Pseudonocardiaceae</italic>: <italic>Amycolatopsis coloradensis</italic> DSM 44225 (GCF_001953865) &#x02013; avoparcin producer (<xref rid="ref42" ref-type="bibr">Kunstmann et al., 1968</xref>; <xref rid="ref44" ref-type="bibr">Labeda, 1995</xref>); <italic>Amycolatopsis decaplanina</italic> DSM 44594 (GCF_000342005, <xref rid="ref39" ref-type="bibr">Kaur et al., 2013</xref>) &#x02013; decaplanin producer (<xref rid="ref69" ref-type="bibr">Sanchez et al., 1992</xref>); <italic>Amycolatopsis keratiniphila</italic> subsp. <italic>nogabecina</italic> DSM 44586 (=<italic>Amycolatopsis keratiniphila</italic> subsp. <italic>nogabecina</italic> FH1893, GCF_001953855) &#x02013; nogabecin producer (<xref rid="ref84" ref-type="bibr">Wink et al., 2003</xref>); <italic>Amycolatopsis</italic> sp. MJM2582 (KF882511, <xref rid="ref78" ref-type="bibr">Truman et al., 2014</xref>), <italic>Amycolatopsis lurida</italic> NRRL2430 (KJ364518, <xref rid="ref78" ref-type="bibr">Truman et al., 2014</xref>), <italic>Amycolatopsis japonicum</italic> MG417-CF17 (CP008953, <xref rid="ref76" ref-type="bibr">Spohn et al., 2014</xref>) &#x02013; ristocetin producers; <italic>Amycolatopsis</italic> sp. WAC4169 (JX576190, <xref rid="ref77" ref-type="bibr">Thaker et al., 2013</xref>) &#x02013; producer of teicoplanin aglycone-like GPA; <italic>Amycolatopsis orientalis</italic> HCCB10007 (=<italic>Am. keratiniphila</italic>, GCA_000400635, <xref rid="ref87" ref-type="bibr">Xu et al., 2014</xref>) and <italic>Amycolatopsis orientalis</italic> KCTC 9412 (=<italic>Am. orientalis</italic> DSM 40040, GCF_000478275, <xref rid="ref38" ref-type="bibr">Jeong et al., 2013</xref>) &#x02013; vancomycin producers; <italic>Amycolatopsis orientalis</italic> CPCC200066 (=<italic>Am. orientalis</italic> B-37, NZ_CP016174, <xref rid="ref46" ref-type="bibr">Lei et al., 2015</xref>) &#x02013; norvancomycin producer; <italic>Amycolatopsis balhimycina</italic> DSM 5908 (Y16952, <xref rid="ref71" ref-type="bibr">Shawky et al., 2007</xref>) &#x02013; balhimycin producer (<xref rid="ref55" ref-type="bibr">Nadkarni et al., 1994</xref>; <xref rid="ref84" ref-type="bibr">Wink et al., 2003</xref>); <italic>Kibdelosporangium aridum</italic> DSM 43828 (GCF_900176515) &#x02013; the producer of kibdelins (<xref rid="ref72" ref-type="bibr">Shearer et al., 1985</xref>), (B) genus <italic>Actinoplanes</italic> (please see main text for more details), (C) genus <italic>Nonomuraea</italic> (please see main text for more details), (D) genus <italic>Streptomyces</italic> (please see main text for more details); although <italic>S. coelicolor</italic> is not a GPA producer, organization of <italic>S. coelicolor van</italic> gene orthologues is also given, and (E) metagenomics sequences (please see main text for more details).</p></caption><graphic xlink:href="fmicb-11-01173-g001"/></fig><p>Thus far, the majority of GPA BGCs were found in members of the genus <italic>Amycolatopsis</italic> (<xref rid="ref1" ref-type="bibr">Adamek et al., 2018</xref>), which belongs to the <italic>Pseudonocardiaceae</italic> family. Besides the vancomycin producers, other <italic>Amycolatopsis</italic> spp. produce avoparcin, decaplanin, nogabecin, ristocetin, teicoplanin aglycone-like GPA, norvancomycin, balhimycin, and chloroeremomycin. In their corresponding BGCs, <italic>van</italic> genes were found just upstream the genes coding for the StrR-like pathway-specific regulators (orthologues of <italic>bbr</italic> from balhimycin BGC, <xref rid="fig1" ref-type="fig">Figure 1</xref>). We excluded from this comparison the chloroeremomycin BGC from <italic>Amycolatopsis orientalis</italic> PA-42867 (?) (<xref rid="ref79" ref-type="bibr">van Wageningen et al., 1998</xref>), which apparently was not completely covered with sequencing. Thus, three patterns for the organization of <italic>van</italic> genes are recognizable (<xref rid="fig1" ref-type="fig">Figure 1</xref>) in <italic>Pseudonocardiaceae</italic> GPA producers. In the producers of avoparcin, decaplanin, nogabecin, ristocetin, and teicoplanin-like aglycone GPA, the GPA BGCs carry <italic>vanHAX</italic> orthologues, but not <italic>vanY</italic> or <italic>vanRS</italic> orthologues. In vancomycin and norvancomycin producers, <italic>vanY</italic> orthologues are clustered with <italic>vanHAX</italic> ones. Balhimycin producer &#x02013; <italic>Amycolatopsis balhimycina</italic> &#x02013; possesses a BGC with <italic>vanRS</italic> (<italic>vlnR<sub>Ab</sub>S<sub>Ab</sub></italic>) and <italic>vanY</italic> (<italic>vanY<sub>Ab</sub></italic>) orthologues, but <italic>vanHAX</italic> orthologues (<italic>vanH<sub>Ab</sub>A<sub>Ab</sub>X<sub>Ab</sub></italic>) were actually found 2 kbp away from balhimycin BGC (<xref rid="ref70" ref-type="bibr">Sch&#x000e4;berle et al., 2011</xref>; <xref rid="ref30" ref-type="bibr">Frasch et al., 2015</xref>). Indeed, no cluster-situated <italic>van</italic> genes were found sequencing the genome of <italic>Kibdelosporangium aridum</italic> &#x02013; the producer of kibdelins (<xref rid="ref73" ref-type="bibr">Shearer et al., 1986</xref>) &#x02013; which also belongs to <italic>Pseudonocardiaceae</italic> family (<xref rid="fig1" ref-type="fig">Figure 1</xref>).</p><p>Other known GPA BGCs are from <italic>Actinoplanes</italic> spp. (family <italic>Micromonosporaceae</italic>) and <italic>Nonomuraea</italic> spp. (family <italic>Streptosporangiaceae</italic>). <italic>Act. teichomyceticus</italic> and <italic>Actinoplanes</italic> sp. ATCC 53533 produce teicoplanin (<xref rid="ref12" ref-type="bibr">Bardone et al., 1978</xref>) and UK-68,597 (<xref rid="ref74" ref-type="bibr">Skelton et al., 1990</xref>), respectively. Teicoplanin BGC (named <italic>tei</italic>) contains <italic>vanHAX</italic> and <italic>vanRS</italic> orthologues (<italic>tei7-6-5</italic> and <italic>tei2-3</italic>, respectively) organized in two separate operons, but none <italic>vanY</italic> orthologue (<xref rid="fig1" ref-type="fig">Figure 1</xref>; <xref rid="ref47" ref-type="bibr">Li et al., 2004</xref>; <xref rid="ref90" ref-type="bibr">Yushchuk et al., 2020b</xref>). In contrast, UK-68,597 BGC contains a <italic>vanH</italic>, not contiguous <italic>vanR</italic> and <italic>vanS</italic>, and a <italic>vanY</italic> orthologue (<xref rid="fig1" ref-type="fig">Figure 1</xref>; <xref rid="ref88" ref-type="bibr">Yim et al., 2014</xref>). In the genus <italic>Nonomuraea</italic>, <italic>N. gerenzanenis</italic> ATCC 39727 and <italic>Nonomuraea</italic> sp. ATCC 55076 produce A40926 (<xref rid="ref31" ref-type="bibr">Goldstein et al., 1987</xref>) and the type V glycopeptide kistamicin (<xref rid="ref56" ref-type="bibr">Naruse et al., 1993</xref>), respectively. In A40926 BGC (named <italic>dbv</italic>) (<xref rid="ref75" ref-type="bibr">Sosio et al., 2003</xref>), <italic>vanR</italic> and <italic>vanS</italic> homologues (<italic>dbv6</italic> and <italic>dbv22</italic>, respectively) are not contiguous and GPA resistance is due to the expression of <italic>vanY</italic> orthologue (<italic>dbv7</italic>, <xref rid="fig1" ref-type="fig">Figure 1</xref>; <xref rid="ref51" ref-type="bibr">Marcone et al., 2010</xref>, <xref rid="ref50" ref-type="bibr">2014</xref>; <xref rid="ref22" ref-type="bibr">Binda et al., 2012</xref>; ). No <italic>vanHAXY</italic> genes are present in kistamicin BGC, although kistamicin BGC contains homologues of <italic>vanS</italic> and <italic>vanR</italic> named <italic>kisG</italic> and <italic>kisB</italic> (<xref rid="ref57" ref-type="bibr">Nazari et al., 2017</xref>).</p><p>GPAs are also produced by few <italic>Streptomyces</italic> species (<xref rid="fig1" ref-type="fig">Figure 1</xref>). Interestingly, functional <italic>van</italic> genes were also found in <italic>S. coelicolor</italic>, which is not a GPA producer (<xref rid="ref35" ref-type="bibr">Hong et al., 2004</xref>). A47934 BGC from <italic>Streptomyces toyocaensis</italic> NRRL 15009 contains <italic>vanH<sub>St</sub>A<sub>St</sub>X<sub>St</sub></italic> and <italic>vanR<sub>St</sub>S<sub>St</sub></italic> operons, together with <italic>staO</italic> and <italic>staP</italic> orthologues to <italic>S. coelicolor vanJ</italic> and <italic>vanK</italic>, respectively (<xref rid="ref64" ref-type="bibr">Pootoolal et al., 2002</xref>). Pekiskomycin BGC from <italic>Streptomyces</italic> sp. WAC1420 contains <italic>vanY</italic>, <italic>vanJ</italic> as well as <italic>vanHAX</italic> and <italic>vanRS</italic> homologues, but pekiskomycin BGC from <italic>Streptomyces</italic> sp. WAC4229 lacks <italic>vanRS</italic> homologues (<xref rid="ref77" ref-type="bibr">Thaker et al., 2013</xref>). No homologues of <italic>van</italic> genes were found in complestatin (type V GPA) BGC from <italic>S. lavendulae</italic> SANK 60477 (?) (<xref rid="ref24" ref-type="bibr">Chiu et al., 2001</xref>), although this antibiotic possesses a moderate antibacterial activity. However, complestatin was shown to inhibit the fatty acid biosynthesis in Gram-positive bacteria (<xref rid="ref43" ref-type="bibr">Kwon et al., 2015</xref>), therefore the producer may require no cell wall remodeling for complestatin self-resistance. Finally, feglymycin BGC from <italic>Streptomyces</italic> sp. DSM11171 (<xref rid="fig1" ref-type="fig">Figure 1</xref>) encodes for a 13-mer peptide antibiotic acting on bacterial cell wall biosynthesis by inhibiting MurA and MurC. Albeit the structure and the mode of action of feglymycin differs from the ones of GPAs, feglymycin BGC shares a high level of similarity with GPA BGCs (<xref rid="ref32" ref-type="bibr">Gonsior et al., 2015</xref>; <xref rid="ref89" ref-type="bibr">Yushchuk et al., 2020a</xref>), including the presence of <italic>vanRS</italic>-like genes &#x02013; <italic>fegM</italic> and <italic>fegN</italic>.</p><p>To conclude, CA915, CA37, and CA878 GPA BGCs (<xref rid="ref10" ref-type="bibr">Banik et al., 2010</xref>), which were sequenced from metagenomics samples, contain <italic>vanHAX</italic>, <italic>vanY</italic> and <italic>vanRS</italic> homologues, whereas none <italic>van</italic> gene was found in other metagenome-derived GPA BGCs as TEG and VEG (<xref rid="ref11" ref-type="bibr">Banik and Brady, 2008</xref>; <xref rid="fig1" ref-type="fig">Figure 1</xref>).</p></sec><sec id="sec4"><title>Updating On What Is Known About The <italic>In Vivo</italic> Function Of <italic>Van</italic> Genes In Gpa-Producing Strains</title><p>Although <italic>van</italic> genes were found in multiple GPA BGCs, only for few of them the function was experimentally proven. Balhimycin resistance in <italic>Am. balhimycina</italic> is likely the most deeply investigated model among GPA producers (<xref rid="fig2" ref-type="fig">Figure 2A</xref>). <italic>vanH<sub>Ab</sub>A<sub>Ab</sub>X<sub>Ab</sub></italic>, that is located outside the BGC (<xref rid="fig1" ref-type="fig">Figure 1</xref>), was shown to be constitutively expressed through all the periods of growth and during balhimycin production (<xref rid="ref70" ref-type="bibr">Sch&#x000e4;berle et al., 2011</xref>). Deletion of <italic>vanH<sub>Ab</sub>A<sub>Ab</sub>X<sub>Ab</sub></italic> genes makes <italic>Am. balhimycina</italic> significantly more sensitive to its own product, decreasing its MIC from 5 to 0.25 mg/ml, and causing an earlier expression of the BGC-situated <italic>vanY<sub>Ab</sub></italic> (<xref rid="ref30" ref-type="bibr">Frasch et al., 2015</xref>). However, <italic>vanY<sub>Ab</sub></italic> itself does not play a decisive role in GPA-resistance since its deletion did not alter the GPA resistance phenotype (<xref rid="ref30" ref-type="bibr">Frasch et al., 2015</xref>). Double <italic>vanH<sub>Ab</sub>A<sub>Ab</sub>X<sub>Ab</sub></italic> and <italic>vanY<sub>Ab</sub></italic> knocked-out mutants showed the same GPA resistance phenotype as &#x00394;<italic>vanH<sub>Ab</sub>A<sub>Ab</sub>X<sub>Ab</sub></italic>. PG precursors ending in <sc>d</sc>-Ala-<sc>d</sc>-Lac were still found in the single &#x00394;<italic>vanH<sub>Ab</sub>A<sub>Ab</sub>X<sub>Ab</sub></italic> and in the double &#x00394;<italic>vanH<sub>Ab</sub>A<sub>Ab</sub>X<sub>Ab</sub></italic> &#x00394;<italic>vanY<sub>Ab</sub></italic> mutants together with <sc>d</sc>-Ala-<sc>d</sc>-Ala ending PG precursors and tetrapeptides (<xref rid="ref30" ref-type="bibr">Frasch et al., 2015</xref>). The residual GPA resistance in these mutants is probably due to an accessory Ddl1<sub>Ab</sub>, a putative <sc>d</sc>-Ala-<sc>d</sc>-Lac ligase encoded in the genome of <italic>Am. balhimycina</italic>, which shares 72% of amino acid sequence identity with VanA<sub>Ab</sub> (<xref rid="ref30" ref-type="bibr">Frasch et al., 2015</xref>). Ddl1<sub>Ab</sub> might add <sc>d</sc>-Lac to the tetrapeptide PG precursors generated by the <sc>d</sc>,<sc>d</sc>-carboxypetidase VanY<sub>Ab</sub> (although the presence of some other <sc>d</sc>-Ala-<sc>d</sc>-Ala carboxypeptidases encoded in the genome cannot be completely ruled out considering the resistant phenotype of the &#x00394;<italic>vanY<sub>Ab</sub></italic> mutant). In the absence of VanH<sub>Ab</sub>, <sc>d</sc>-Lac for this reaction is probably obtained from the primary metabolic pool. Expression of <italic>vanH<sub>Ab</sub>A<sub>Ab</sub>X<sub>Ab</sub></italic> was demonstrated to be independent from the BGC-situated regulator <italic>vlnR<sub>Ab</sub></italic> (<xref rid="ref40" ref-type="bibr">Kilian et al., 2016</xref>). However, VlnR<sub>Ab</sub> is important for the activation of the BGC-situated <italic>vanY<sub>Ab</sub></italic> expression (<xref rid="ref40" ref-type="bibr">Kilian et al., 2016</xref>). Heterologous expression of <italic>vlnR<sub>Ab</sub>S<sub>Ab</sub></italic> in <italic>S. coelicolor</italic> &#x00394;<italic>vanRS</italic> mutants indicated that both VlnR<sub>Ab</sub> and VlnS<sub>Ab</sub> are active and able to replace their counterparts VanR and VanS, which in <italic>S. coelicolor</italic> control the expression of <italic>vanHAX</italic> genes in response to vancomycin (<xref rid="ref35" ref-type="bibr">Hong et al., 2004</xref>), restoring resistance to both balhimycin and teicoplanin in the complemented strains (<xref rid="ref40" ref-type="bibr">Kilian et al., 2016</xref>). Overall, it seems that the BGC-situated <italic>vlnR<sub>Ab</sub>S<sub>Ab</sub>-vanY<sub>Ab</sub></italic> regulatory circuit is functional, but does not play a major role in balhimycin resistance, which is mostly determined by <italic>vanH<sub>Ab</sub>A<sub>Ab</sub>X<sub>Ab</sub></italic> expression. It would be interesting to test GPA resistance in <italic>ddl1<sub>Ab</sub></italic> knocked-out mutant generated in <italic>Am. balhimycina</italic> &#x00394;<italic>vanH<sub>Ab</sub>A<sub>Ab</sub>X<sub>Ab</sub></italic> &#x00394;<italic>vanY<sub>Ab</sub></italic> to better understand the role of this accessory ligase and its connection with the <sc>d</sc>,<sc>d</sc>-carboxypetidase activity of VanY<sub>Ab</sub> (or of some other still-unknown carboxypeptidases).</p><fig id="fig2" position="float"><label>Figure 2</label><caption><p>Knowledge-based conceptual schemes for the GPA self-resistance mechanisms and their regulation in model GPA-producers: <bold>(A)</bold>
<italic>Am. balhimycina</italic>, the producer of balhimycin, <bold>(B)</bold>
<italic>Act. teichomyceticus</italic>, the producer of teicoplanin, <bold>(C)</bold>
<italic>N. gerenzanensis</italic>, the producer of A40926, and <bold>(D)</bold>
<italic>S. toyocaensis</italic>, the producer of A47934. Please refer to main text for more details on genes involved in GPA self-resistance. Please note that <italic>tei4</italic> in <italic>Act. teichomyceticus</italic>, <italic>dbv5</italic> and <italic>dbv23</italic> in <italic>N. gerenzanensis</italic>, and <italic>murX</italic> in <italic>S. toyocaensis</italic>, colored in light gray, are not <italic>van</italic> gene orthologues, but they are reported since they are close to <italic>van</italic> genes or part of their operons.</p></caption><graphic xlink:href="fmicb-11-01173-g002"/></fig><p>Differently from <italic>Am. balhimycina</italic>, in <italic>Act. teichomyceticus vanHAX</italic> orthologues &#x02013; <italic>tei7-6-5</italic> &#x02013; are located within the <italic>tei</italic> BGC together with <italic>vanRS</italic> orthologues &#x02013; <italic>tei2-3</italic> (<xref rid="fig2" ref-type="fig">Figure 2B</xref>). <italic>tei7-6-5</italic> expression determines the production of PG precursors ending in <sc>d</sc>-Ala-<sc>d</sc>-Lac, conferring a GPA-resistant phenotype to <italic>Act. teichomyceticus</italic> (<xref rid="ref15" ref-type="bibr">Beltrametti et al., 2007</xref>; <xref rid="ref19" ref-type="bibr">Binda et al., 2018</xref>). Interestingly, the expression of <italic>tei7-6-5</italic> operon is constant during the growth curve and in teicoplanin production conditions (<xref rid="ref15" ref-type="bibr">Beltrametti et al., 2007</xref>; <xref rid="ref91" ref-type="bibr">Yushchuk et al., 2019</xref>) and the VanX <sc>d</sc>,<sc>d</sc>-dipeptidase activity was detectable in cellular extracts independently from the addition of teicoplanin (<xref rid="ref19" ref-type="bibr">Binda et al., 2018</xref>). One probable reason for the constitutive expression of <italic>tei7-6-5</italic> is the non-inducibility of the sensor histidine kinase Tei3, due to its point mutations previously known to confer a constitutive kinase activity to <italic>S. coelicolor</italic> VanS (<xref rid="ref15" ref-type="bibr">Beltrametti et al., 2007</xref>). Also, the expression of <italic>vanRS</italic> orthologues &#x02013; <italic>tei2-3</italic> &#x02013; was also found constitutive under teicoplanin production conditions (<xref rid="ref91" ref-type="bibr">Yushchuk et al., 2019</xref>) and these genes are co-expressed with <italic>tei4</italic> &#x02013; coding for a dehydrofolate reductase with no obvious role in teicoplanin-resistance (<xref rid="ref90" ref-type="bibr">Yushchuk et al., 2020b</xref>). Moreover, <italic>tei2-3-4</italic> expression is independent from <italic>tei</italic> cluster-encoded transcriptional regulators &#x02013; Tei15* and Tei16* (<xref rid="ref91" ref-type="bibr">Yushchuk et al., 2019</xref>, <xref rid="ref90" ref-type="bibr">2020b</xref>). Constitutive expression of <italic>tei2-3-4</italic> could be granted by <italic>tei2</italic> promoter, which was shown to be highly active in <italic>Act. teichomyceticus</italic>, starting from the very early stage of spore germination (<xref rid="ref90" ref-type="bibr">Yushchuk et al., 2020b</xref>). More investigations are required for a complete understanding of teicoplanin-resistance in <italic>Act. teichomyceticus</italic>. Study of the Tei3 properties is among the most interesting tasks.</p><p>In <italic>N. gerenzanensis</italic> producing the teicoplanin-like A40926, <italic>vanHAX</italic> orthologues were not found neither in the BGC nor in the genome (<xref rid="ref27" ref-type="bibr">D&#x02019;Argenio et al., 2016</xref>). The only known mechanism of resistance relies on the action of VanY<sub>n</sub>, whose coding gene (<italic>dbv7</italic>) is within the <italic>dbv</italic> BGC (<xref rid="fig2" ref-type="fig">Figure 2C</xref>) and whose knockout abolishes the resistance phenotype (<xref rid="ref51" ref-type="bibr">Marcone et al., 2010</xref>, <xref rid="ref50" ref-type="bibr">2014</xref>; <xref rid="fig2" ref-type="fig">Figure 2C</xref>). VanY<sub>n</sub> is a <sc>d</sc>,<sc>d</sc>-carboxypeptidase that cleaves the last <sc>d</sc>-Ala from pentapeptide PG precursors generating tetrapeptides, drastically reducing GPA affinity for cellular targets (<xref rid="ref22" ref-type="bibr">Binda et al., 2012</xref>). A <sc>l</sc>,<sc>d</sc>-transpeptidase (Ldt) then uses the tetrapeptide acyl donors supplied by VanY<sub>n</sub> to synthetize the mature cell wall (<xref rid="ref37" ref-type="bibr">Hugonnet et al., 2014</xref>). The role of this protein and its features that assimilate/distinguish it from enterococcal VanY and from VanY<sub>Ab</sub> were investigated in detail (<xref rid="ref51" ref-type="bibr">Marcone et al., 2010</xref>, <xref rid="ref50" ref-type="bibr">2014</xref>; <xref rid="ref22" ref-type="bibr">Binda et al., 2012</xref>, <xref rid="ref21" ref-type="bibr">2013</xref>). Less clear is the regulatory circuit governing <italic>dbv7</italic> expression. Direct VanY<sub>n</sub> carboxypeptidase activity measurement in <italic>N. gerenzanensis</italic> growing with the addition of different GPAs, unambiguously showed that VanY<sub>n</sub> activity is induced by vancomycin, teicoplanin, and A40926 (<xref rid="ref19" ref-type="bibr">Binda et al., 2018</xref>). <italic>vanRS</italic> homologues &#x02013; <italic>dbv6</italic> and <italic>dbv22</italic> &#x02013; are present in the <italic>dbv</italic> BGC, but the knockout of <italic>dbv6</italic> did not exert any influence on A40926 production and growth of <italic>N. gerenzanensis</italic> (<xref rid="ref48" ref-type="bibr">Lo Grasso et al., 2015</xref>). Unfortunately, the GPA resistance phenotype of this mutant was not described. On the other side, transcriptional analysis of <italic>dbv</italic> genes indicated that the expression of <italic>dbv5-6-7</italic> and <italic>dbv23-22</italic> operons is rather constitutive (<xref rid="ref3" ref-type="bibr">Alduina et al., 2007</xref>). Although the presence of other GPA-sensitive TCS beyond the borders of A40926 BGC cannot be ruled out, role of Dbv6 and Dbv22 in <italic>N. gerenzanensis</italic> A40926 self-resistance merits further investigations.</p><p>Finally, <italic>S. toyocaensis</italic> possesses, perhaps, the most straightforward resistance mechanism among all the investigated GPA producers (<xref rid="fig2" ref-type="fig">Figure 2D</xref>), reminding the situation in <italic>S. coelicolor</italic> (<xref rid="ref35" ref-type="bibr">Hong et al., 2004</xref>). The BGC-located <italic>vanH<sub>St</sub>A<sub>St</sub>X<sub>St</sub></italic> operon was shown to be crucial for A47934 resistance and <italic>vanA<sub>St</sub></italic> knockout made <italic>S. toyocaensis</italic> completely sensitive to A47934 (<xref rid="ref64" ref-type="bibr">Pootoolal et al., 2002</xref>). At the same time, <italic>vanHAX</italic>-genes from the vancomycin producer <italic>Am. orientalis</italic> C329.2 were able to restore A47934 resistance phenotype in the knocked-out mutant (<xref rid="ref64" ref-type="bibr">Pootoolal et al., 2002</xref>). Functions of VanR<sub>St</sub> and VanS<sub>St</sub> (both present in the A47934 BGC, <xref rid="fig1" ref-type="fig">Figures 1</xref>, <xref rid="fig2" ref-type="fig">2D</xref>) were also studied in detail, showing that VanS<sub>St</sub> has a remarkable specificity for A47934 and it is unable to sense teicoplanin or vancomycin (<xref rid="ref41" ref-type="bibr">Koteva et al., 2010</xref>; <xref rid="ref59" ref-type="bibr">Novotna et al., 2016</xref>). Moreover, also the interaction between VanR<sub>St</sub> and VanS<sub>St</sub> was found to be very specific, since VanR<sub>St</sub> could not be phosphorylated by a non-cognate sensor-histidine kinase (<xref rid="ref59" ref-type="bibr">Novotna et al., 2016</xref>). The roles (if there are any) of <italic>staP</italic> and <italic>staO</italic> (orthologues of <italic>S. coelicolor vanK</italic> and <italic>vanJ</italic>) in <italic>S. toyocaensis</italic> A47934 self-resistance were not investigated, thus the importance of these auxiliary resistance genes remains to be proved.</p></sec><sec id="sec5"><title>Outlook</title><p>Soil GPA producers are considered the putative source of GPA resistance determinants, which might had been recruited and differently combined in pathogens. The goal of this mini review is to update the knowledge on the occurrence and role of <italic>van</italic> genes in producing microorganisms. It emerges that more <italic>in silico</italic>, <italic>in vitro</italic>, and <italic>in vivo</italic> investigations on their function and regulation are required to shed light on the intriguing issue of their origin and role. Overall, a detailed phylogenetic analysis would be useful to illuminate the evolution of GPA-resistant determinants in GPA producers and from them to pathogens. A recent pioneering work on the reconstruction of GPA BGC phylogeny (<xref rid="ref81" ref-type="bibr">Waglechner et al., 2019</xref>) reported on the possible origin and evolution of GPA cluster-situated <italic>van</italic>-genes. According to these authors, <italic>vanA</italic> had likely originated within <italic>Amycolatopsis</italic> genus, whereas <italic>vanH</italic>, <italic>vanX</italic>, and <italic>vanRS</italic> within <italic>Actinoplanes</italic>; and <italic>vanY</italic> probably originated within genus <italic>Nonomuraea</italic> and it was then distributed among GPA BGCs by multiple transfer events. Combination of these genes in pathogens is today determining the urgent clinical need for new drugs to combat multi-drug resistant Gram-positive pathogens.</p></sec><sec id="sec6"><title>Author Contributions</title><p>EB and OY collected data and papers and co-wrote the review. OY prepared the figures. FM and EB supervised the work.</p></sec><sec sec-type="coi" id="sec7"><title>Conflict of Interest</title><p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p></sec></body><back><ack><p>We are grateful to Consorzio Italbiotec for supporting EB.</p></ack><fn-group><fn fn-type="financial-disclosure"><p><bold>Funding.</bold> This work was supported by grant &#x0201c;Fondo di Ateneo per la Ricerca&#x0201d; 2017, 2018 to FM, and Consorzio Italbiotec to EB.</p></fn></fn-group><ref-list><title>References</title><ref id="ref1"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Adamek</surname><given-names>M.</given-names></name><name><surname>Alanjary</surname><given-names>M.</given-names></name><name><surname>Sales-Ortells</surname><given-names>H.</given-names></name><name><surname>Goodfellow</surname><given-names>M.</given-names></name><name><surname>Bull</surname><given-names>A. T.</given-names></name><name><surname>Winkler</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Comparative genomics reveals phylogenetic distribution patterns of secondary metabolites in <italic>Amycolatopsis</italic> species</article-title>. <source>BMC Genomics</source>
<volume>19</volume>:<fpage>426</fpage>. <pub-id pub-id-type="doi">10.1186/s12864-018-4809-4</pub-id>, PMID: <?supplied-pmid 29859036?><pub-id pub-id-type="pmid">29859036</pub-id></mixed-citation></ref><ref id="ref2"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ahmed</surname><given-names>M. O.</given-names></name><name><surname>Baptiste</surname><given-names>K. E.</given-names></name></person-group> (<year>2018</year>). <article-title>Vancomycin-resistant enterococci: a review of antimicrobial resistance mechanisms and perspectives of human and animal health</article-title>. <source>Microb. Drug Resist.</source>
<volume>24</volume>, <fpage>590</fpage>&#x02013;<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1089/mdr.2017.0147</pub-id>, PMID: <?supplied-pmid 29058560?><pub-id pub-id-type="pmid">29058560</pub-id></mixed-citation></ref><ref id="ref3"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Alduina</surname><given-names>R.</given-names></name><name><surname>Piccolo</surname><given-names>L. L.</given-names></name><name><surname>Dalia</surname><given-names>D.</given-names></name><name><surname>Ferraro</surname><given-names>C.</given-names></name><name><surname>Gunnarsson</surname><given-names>N.</given-names></name><name><surname>Donadio</surname><given-names>S.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>Phosphate-controlled regulator for the biosynthesis of the dalbavancin precursor A40926</article-title>. <source>J. Bacteriol.</source>
<volume>189</volume>, <fpage>8120</fpage>&#x02013;<lpage>8129</lpage>. <pub-id pub-id-type="doi">10.1128/JB.01247-07</pub-id>, PMID: <?supplied-pmid 17873036?><pub-id pub-id-type="pmid">17873036</pub-id></mixed-citation></ref><ref id="ref6"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arthur</surname><given-names>M.</given-names></name><name><surname>Depardieu</surname><given-names>F.</given-names></name><name><surname>Cabani&#x000e9;</surname><given-names>L.</given-names></name><name><surname>Reynolds</surname><given-names>P.</given-names></name><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group> (<year>1998</year>). <article-title>Requirement of the VanY and VanX <sc>d</sc>,<sc>d</sc>-peptidases for glycopeptide resistance in enterococci</article-title>. <source>Mol. Mirobiol.</source>
<volume>30</volume>, <fpage>819</fpage>&#x02013;<lpage>830</lpage>. <pub-id pub-id-type="doi">10.1046/j.1365-2958.1998.01114.x</pub-id>, PMID: <?supplied-pmid 10094630?><pub-id pub-id-type="pmid">10094630</pub-id></mixed-citation></ref><ref id="ref5"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arthur</surname><given-names>M.</given-names></name><name><surname>Depardieu</surname><given-names>F.</given-names></name><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group> (<year>1999</year>). <article-title>Regulated interactions between partner and non-partner sensors and response regulators that control glycopeptide resistance gene expression in enterococci</article-title>. <source>Microbiologica</source>
<volume>145</volume>, <fpage>1849</fpage>&#x02013;<lpage>1858</lpage>. <pub-id pub-id-type="doi">10.1099/13500872-145-8-1849</pub-id>, PMID: <?supplied-pmid 10463151?><pub-id pub-id-type="pmid">10463151</pub-id></mixed-citation></ref><ref id="ref7"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arthur</surname><given-names>M.</given-names></name><name><surname>Depardieu</surname><given-names>F.</given-names></name><name><surname>Gerbaud</surname><given-names>G.</given-names></name><name><surname>Galimand</surname><given-names>M.</given-names></name><name><surname>Leclercq</surname><given-names>R.</given-names></name><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group> (<year>1997</year>). <article-title>The VanS sensor negatively controls VanR-mediated transcriptional activation of glycopeptide resistance genes of <italic>Tn1546</italic> and related elements in the absence of induction</article-title>. <source>J. Bacteriol.</source>
<volume>179</volume>, <fpage>97</fpage>&#x02013;<lpage>106</lpage>. <pub-id pub-id-type="doi">10.1128/JB.179.1.97-106.1997</pub-id>, PMID: <?supplied-pmid 8981985?><pub-id pub-id-type="pmid">8981985</pub-id></mixed-citation></ref><ref id="ref9"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arthur</surname><given-names>M.</given-names></name><name><surname>Molinas</surname><given-names>C.</given-names></name><name><surname>Bugg</surname><given-names>T. D.</given-names></name><name><surname>Wright</surname><given-names>G. D.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group> (<year>1992</year>). <article-title>Evidence for in vivo incorporation of <sc>d</sc>-lactate into peptidoglycan precursors of vancomycin-resistant enterococci</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>36</volume>, <fpage>867</fpage>&#x02013;<lpage>869</lpage>. <pub-id pub-id-type="doi">10.1128/aac.36.4.867</pub-id><pub-id pub-id-type="pmid">1503450</pub-id></mixed-citation></ref><ref id="ref4"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arthur</surname><given-names>M.</given-names></name><name><surname>Quintiliani</surname><given-names>R.</given-names></name></person-group> (<year>2001</year>). <article-title>Regulation of VanA&#x02010; and VanB-type glycopeptide resistance in enterococci</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>45</volume>, <fpage>375</fpage>&#x02013;<lpage>381</lpage>. <pub-id pub-id-type="doi">10.1128/aac.45.2.375-381.2001</pub-id><pub-id pub-id-type="pmid">11158729</pub-id></mixed-citation></ref><ref id="ref8"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Arthur</surname><given-names>M.</given-names></name><name><surname>Reynolds</surname><given-names>P.</given-names></name><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group> (<year>1996</year>). <article-title>Glycopeptide resistance in enterococci</article-title>. <source>Trends Microbiol.</source>
<volume>4</volume>, <fpage>401</fpage>&#x02013;<lpage>407</lpage>. <pub-id pub-id-type="doi">10.1016/0966-842X(96)10063-9</pub-id>, PMID: <?supplied-pmid 8899966?><pub-id pub-id-type="pmid">8899966</pub-id></mixed-citation></ref><ref id="ref11"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banik</surname><given-names>J. J.</given-names></name><name><surname>Brady</surname><given-names>S. F.</given-names></name></person-group> (<year>2008</year>). <article-title>Cloning and characterization of new glycopeptide gene clusters found in an environmental DNA megalibrary</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>105</volume>, <fpage>17273</fpage>&#x02013;<lpage>17277</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0807564105</pub-id><pub-id pub-id-type="pmid">18987322</pub-id></mixed-citation></ref><ref id="ref10"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Banik</surname><given-names>J. J.</given-names></name><name><surname>Craig</surname><given-names>J. W.</given-names></name><name><surname>Calle</surname><given-names>P. Y.</given-names></name><name><surname>Brady</surname><given-names>S. F.</given-names></name></person-group> (<year>2010</year>). <article-title>Tailoring enzyme-rich environmental DNA clones: a source of enzymes for generating libraries of unnatural natural products</article-title>. <source>J. Am. Chem. Soc.</source>
<volume>132</volume>, <fpage>15661</fpage>&#x02013;<lpage>15670</lpage>. <pub-id pub-id-type="doi">10.1021/ja105825a</pub-id><pub-id pub-id-type="pmid">20945895</pub-id></mixed-citation></ref><ref id="ref12"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bardone</surname><given-names>M. R.</given-names></name><name><surname>Paternoster</surname><given-names>M.</given-names></name><name><surname>Coronelli</surname><given-names>C.</given-names></name></person-group> (<year>1978</year>). <article-title>Teichomycins, new antibiotics from <italic>Actinoplanes teichomyceticus</italic> nov. sp. II. Extraction and chemical characterization</article-title>. <source>J. Antibiot.</source>
<volume>31</volume>, <fpage>170</fpage>&#x02013;<lpage>177</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.31.170</pub-id>, PMID: <?supplied-pmid 649512?><pub-id pub-id-type="pmid">649512</pub-id></mixed-citation></ref><ref id="ref13"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barka</surname><given-names>E. A.</given-names></name><name><surname>Vatsa</surname><given-names>P.</given-names></name><name><surname>Sanchez</surname><given-names>L.</given-names></name><name><surname>Gavetas-Vaillant</surname><given-names>N.</given-names></name><name><surname>Jacquard</surname><given-names>C.</given-names></name><name><surname>Meier-Kolthoff</surname><given-names>J. P.</given-names></name><etal/></person-group> (<year>2015</year>). <article-title>Taxonomy, physiology, and natural products of Actinobacteria</article-title>. <source>Microbiol. Mol. Biol. Rev.</source>
<volume>80</volume>, <fpage>1</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1128/MMBR.00019-15</pub-id><pub-id pub-id-type="pmid">26609051</pub-id></mixed-citation></ref><ref id="ref14"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bartley</surname><given-names>J.</given-names></name></person-group> (<year>2002</year>). <article-title>First case of VRSA identified in Michigan</article-title>. <source>Infect. Control Hosp. Epidemiol.</source>
<volume>23</volume>:<fpage>480</fpage>. <pub-id pub-id-type="doi">10.1017/s0195941700082333</pub-id>, PMID: <?supplied-pmid 12186219?><pub-id pub-id-type="pmid">12186219</pub-id></mixed-citation></ref><ref id="ref15"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Beltrametti</surname><given-names>F.</given-names></name><name><surname>Consolandi</surname><given-names>A.</given-names></name><name><surname>Carrano</surname><given-names>L.</given-names></name><name><surname>Bagatin</surname><given-names>F.</given-names></name><name><surname>Rossi</surname><given-names>R.</given-names></name><name><surname>Leoni</surname><given-names>L.</given-names></name><etal/></person-group> (<year>2007</year>). <article-title>Resistance to glycopeptide antibiotics in the teicoplanin producer is mediated by <italic>van</italic> gene homologue expression directing the synthesis of a modified cell wall peptidoglycan</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>51</volume>, <fpage>1135</fpage>&#x02013;<lpage>1141</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.01071-06</pub-id><pub-id pub-id-type="pmid">17220405</pub-id></mixed-citation></ref><ref id="ref16"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>B&#x000e9;rdy</surname><given-names>J.</given-names></name></person-group> (<year>2012</year>). <article-title>Thoughts and facts about antibiotics: where we are now and where we are heading</article-title>. <source>J. Antibiot.</source>
<volume>65</volume>, <fpage>385</fpage>&#x02013;<lpage>395</lpage>. <pub-id pub-id-type="doi">10.1038/ja.2012.27</pub-id>, PMID: <?supplied-pmid 22511224?><pub-id pub-id-type="pmid">22511224</pub-id></mixed-citation></ref><ref id="ref17"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Biavasco</surname><given-names>F.</given-names></name><name><surname>Giovanetti</surname><given-names>E.</given-names></name><name><surname>Miele</surname><given-names>A.</given-names></name><name><surname>Vignaroli</surname><given-names>C.</given-names></name><name><surname>Facinelli</surname><given-names>B.</given-names></name><name><surname>Varaldo</surname><given-names>P. E.</given-names></name></person-group> (<year>1996</year>). <article-title>In vitro conjugative transfer of VanA vancomycin resistance between Enterococci and <italic>Listeriae</italic> of different species</article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis.</source>
<volume>15</volume>, <fpage>50</fpage>&#x02013;<lpage>59</lpage>. <pub-id pub-id-type="doi">10.1007/BF01586185</pub-id>, PMID: <?supplied-pmid 8641304?><pub-id pub-id-type="pmid">8641304</pub-id></mixed-citation></ref><ref id="ref18"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Billot-Klein</surname><given-names>D.</given-names></name><name><surname>Blanot</surname><given-names>D.</given-names></name><name><surname>Gutmann</surname><given-names>L.</given-names></name><name><surname>van Heijenoort</surname><given-names>J.</given-names></name></person-group> (<year>1994</year>). <article-title>Association constants for the binding of vancomycin and teicoplanin to N-acetyl-<sc>d</sc>-alanyl-<sc>d</sc>-alanine and N-acetyl-<sc>d</sc>-alanyl-<sc>d</sc>-serine</article-title>. <source>Biochem. J.</source>
<volume>304</volume>, <fpage>1021</fpage>&#x02013;<lpage>1022</lpage>. <pub-id pub-id-type="doi">10.1042/bj3041021</pub-id>, PMID: <?supplied-pmid 7818465?><pub-id pub-id-type="pmid">7818465</pub-id></mixed-citation></ref><ref id="ref19"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binda</surname><given-names>E.</given-names></name><name><surname>Cappelletti</surname><given-names>P.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name><name><surname>Marcone</surname><given-names>G. L.</given-names></name></person-group> (<year>2018</year>). <article-title>Specificity of induction of glycopeptide antibiotic resistance in the producing actinomycetes</article-title>. <source>Antibiotics</source>
<volume>7</volume>, <fpage>36</fpage>&#x02013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.3390/antibiotics7020036</pub-id>, PMID: <?supplied-pmid 29693566?><pub-id pub-id-type="pmid">29693566</pub-id></mixed-citation></ref><ref id="ref21"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binda</surname><given-names>E.</given-names></name><name><surname>Marcone</surname><given-names>G. L.</given-names></name><name><surname>Berini</surname><given-names>F.</given-names></name><name><surname>Pollegioni</surname><given-names>L.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name></person-group> (<year>2013</year>). <article-title><italic>Streptomyces</italic> spp. as efficient expression system for a <sc>d</sc>,<sc>d</sc>-peptidase/<sc>d</sc>,<sc>d</sc>-carboxypeptidase involved in glycopeptide antibiotic resistance</article-title>. <source>BMC Biotechnol.</source>
<volume>13</volume>:<fpage>24</fpage>. <pub-id pub-id-type="doi">10.1186/1472-6750-13-24</pub-id>, PMID: <?supplied-pmid 23497129?><pub-id pub-id-type="pmid">23497129</pub-id></mixed-citation></ref><ref id="ref20"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binda</surname><given-names>E.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name><name><surname>Marcone</surname><given-names>G. L.</given-names></name></person-group> (<year>2014</year>). <article-title>Old and new glycopeptide antibiotics: action and resistance</article-title>. <source>Antibiotics</source>
<volume>3</volume>, <fpage>572</fpage>&#x02013;<lpage>594</lpage>. <pub-id pub-id-type="doi">10.3390/antibiotics3040572</pub-id>, PMID: <?supplied-pmid 27025757?><pub-id pub-id-type="pmid">27025757</pub-id></mixed-citation></ref><ref id="ref22"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Binda</surname><given-names>E.</given-names></name><name><surname>Marcone</surname><given-names>G. L.</given-names></name><name><surname>Pollegioni</surname><given-names>L.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name></person-group> (<year>2012</year>). <article-title>Characterization of VanYn, a novel 485 <sc>d</sc>,<sc>d</sc>-peptidase/<sc>d</sc>,<sc>d</sc>-carboxypeptidase involved in glycopeptide antibiotic resistance in <italic>Nonomuraea</italic> sp. ATCC 39727</article-title>. <source>FEBS J.</source>
<volume>279</volume>, <fpage>3203</fpage>&#x02013;<lpage>3213</lpage>. <pub-id pub-id-type="doi">10.1111/j.1742-4874658.2012.08706.x</pub-id>, PMID: <?supplied-pmid 22788848?><pub-id pub-id-type="pmid">22788848</pub-id></mixed-citation></ref><ref id="ref23"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bugg</surname><given-names>T. D.</given-names></name><name><surname>Wright</surname><given-names>G. D.</given-names></name><name><surname>Dutka-Malen</surname><given-names>S.</given-names></name><name><surname>Arthur</surname><given-names>M.</given-names></name><name><surname>Courvalin</surname><given-names>P.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name></person-group> (<year>1991</year>). <article-title>Molecular basis for vancomycin resistance in <italic>Enterococcus faecium</italic> BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA</article-title>. <source>Biochemist</source>
<volume>30</volume>, <fpage>10408</fpage>&#x02013;<lpage>10415</lpage>. <pub-id pub-id-type="doi">10.1021/bi00107a007</pub-id>, PMID: <?supplied-pmid 1931965?><pub-id pub-id-type="pmid">1931965</pub-id></mixed-citation></ref><ref id="ref24"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chiu</surname><given-names>H.-T.</given-names></name><name><surname>Hubbard</surname><given-names>B. K.</given-names></name><name><surname>Shah</surname><given-names>A. N.</given-names></name><name><surname>Eide</surname><given-names>J.</given-names></name><name><surname>Fredenburg</surname><given-names>R. A.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name><etal/></person-group>. (<year>2001</year>). <article-title>Molecular cloning and sequence analysis of the complestatin biosynthetic gene cluster</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>98</volume>, <fpage>8548</fpage>&#x02013;<lpage>8553</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.151246498</pub-id>, PMID: <?supplied-pmid 11447274?><pub-id pub-id-type="pmid">11447274</pub-id></mixed-citation></ref><ref id="ref25"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cong</surname><given-names>Y.</given-names></name><name><surname>Yang</surname><given-names>S.</given-names></name><name><surname>Rao</surname><given-names>X.</given-names></name></person-group> (<year>2020</year>). <article-title>Vancomycin resistant <italic>Staphylococcus aureus</italic> infections: a review of case updating and clinical features</article-title>. <source>J. Adv. Res.</source>
<volume>21</volume>, <fpage>169</fpage>&#x02013;<lpage>176</lpage>. <pub-id pub-id-type="doi">10.1016/j.jare.2019.10.005</pub-id>, PMID: <?supplied-pmid 32071785?><pub-id pub-id-type="pmid">32071785</pub-id></mixed-citation></ref><ref id="ref26"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group> (<year>2006</year>). <article-title>Vancomycin resistance in gram-positive cocci</article-title>. <source>Clin. Infect. Dis.</source>
<volume>42</volume>, <fpage>S25</fpage>&#x02013;<lpage>S34</lpage>. <pub-id pub-id-type="doi">10.1086/491711</pub-id>, PMID: <?supplied-pmid 16323116?><pub-id pub-id-type="pmid">16323116</pub-id></mixed-citation></ref><ref id="ref27"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>D&#x02019;Argenio</surname><given-names>V.</given-names></name><name><surname>Petrillo</surname><given-names>M.</given-names></name><name><surname>Pasanisi</surname><given-names>D.</given-names></name><name><surname>Pagliarulo</surname><given-names>C.</given-names></name><name><surname>Colicchio</surname><given-names>R.</given-names></name><name><surname>Tal&#x000e0;</surname><given-names>A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>The complete 12Mb genome and transcriptome of <italic>Nonomuraea gerenzanensis</italic> with new insights into its duplicated &#x0201c;magic&#x0201d; RNA polymerase</article-title>. <source>Sci. Rep.</source>
<volume>6</volume>, <fpage>1</fpage>&#x02013;<lpage>13</lpage>. <pub-id pub-id-type="doi">10.1038/s41598-016-0025-0</pub-id><pub-id pub-id-type="pmid">28442746</pub-id></mixed-citation></ref><ref id="ref28"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Depardieu</surname><given-names>F.</given-names></name><name><surname>Podglajen</surname><given-names>I.</given-names></name><name><surname>Leclercq</surname><given-names>R.</given-names></name><name><surname>Collatz</surname><given-names>E.</given-names></name><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group> (<year>2007</year>). <article-title>Modes and modulations of antibiotic resistance gene expression</article-title>. <source>Clin. Microbiol. Rev.</source>
<volume>20</volume>, <fpage>79</fpage>&#x02013;<lpage>114</lpage>. <pub-id pub-id-type="doi">10.1128/CMR.00015-06</pub-id>, PMID: <?supplied-pmid 17223624?><pub-id pub-id-type="pmid">17223624</pub-id></mixed-citation></ref><ref id="ref29"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fontana</surname><given-names>R.</given-names></name><name><surname>Ligozzi</surname><given-names>M.</given-names></name><name><surname>Pedrotti</surname><given-names>C.</given-names></name><name><surname>Padovani</surname><given-names>E. M.</given-names></name><name><surname>Cornaglia</surname><given-names>G. C.</given-names></name></person-group> (<year>1997</year>). <article-title>Vancomycin-resistant <italic>Bacillus circulans</italic> carrying the vanA gene responsible for vancomycin resistance in enterococci</article-title>. <source>Eur. J. Clin. Microbiol. Infect. Dis.</source>
<volume>16</volume>, <fpage>473</fpage>&#x02013;<lpage>474</lpage>. <pub-id pub-id-type="doi">10.1007/BF02471915</pub-id>, PMID: <?supplied-pmid 9248754?><pub-id pub-id-type="pmid">9248754</pub-id></mixed-citation></ref><ref id="ref30"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Frasch</surname><given-names>H.-J.</given-names></name><name><surname>Kalan</surname><given-names>L.</given-names></name><name><surname>Kilian</surname><given-names>R.</given-names></name><name><surname>Martin</surname><given-names>T.</given-names></name><name><surname>Wright</surname><given-names>G. D.</given-names></name><name><surname>Stegmann</surname><given-names>E.</given-names></name></person-group> (<year>2015</year>). <article-title>Alternative pathway to a glycopeptide-resistant cell wall in the balhimycin producer <italic>Amycolatopsis balhimycina</italic></article-title>. <source>ACS Infect. Dis.</source>
<volume>1</volume>, <fpage>243</fpage>&#x02013;<lpage>252</lpage>. <pub-id pub-id-type="doi">10.1021/acsinfecdis.5b00011</pub-id>, PMID: <?supplied-pmid 27622740?><pub-id pub-id-type="pmid">27622740</pub-id></mixed-citation></ref><ref id="ref31"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Goldstein</surname><given-names>B. P.</given-names></name><name><surname>Selva</surname><given-names>E.</given-names></name><name><surname>Gastaldo</surname><given-names>L.</given-names></name><name><surname>Berti</surname><given-names>M.</given-names></name><name><surname>Pallanza</surname><given-names>R.</given-names></name><name><surname>Ripamonti</surname><given-names>F.</given-names></name><etal/></person-group>. (<year>1987</year>). <article-title>A40926, a new glycopeptide antibiotic with anti-<italic>Neisseria</italic> activity</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>31</volume>, <fpage>1961</fpage>&#x02013;<lpage>1966</lpage>. <pub-id pub-id-type="doi">10.1128/aac.31.12.1961</pub-id>, PMID: <?supplied-pmid 2964225?><pub-id pub-id-type="pmid">2964225</pub-id></mixed-citation></ref><ref id="ref32"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gonsior</surname><given-names>M.</given-names></name><name><surname>M&#x000fc;hlenweg</surname><given-names>A.</given-names></name><name><surname>Tietzmann</surname><given-names>M.</given-names></name><name><surname>Rausch</surname><given-names>S.</given-names></name><name><surname>Poch</surname><given-names>A.</given-names></name><name><surname>S&#x000fc;ssmuth</surname><given-names>R. D.</given-names></name></person-group> (<year>2015</year>). <article-title>Biosynthesis of the peptide antibiotic feglymycin by a linear nonribosomal peptide synthetase mechanism</article-title>. <source>Chembiochem</source>
<volume>16</volume>, <fpage>2610</fpage>&#x02013;<lpage>2614</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201500432</pub-id>, PMID: <?supplied-pmid 26515424?><pub-id pub-id-type="pmid">26515424</pub-id></mixed-citation></ref><ref id="ref33"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Healy</surname><given-names>V. L.</given-names></name><name><surname>Lessard</surname><given-names>I. A.</given-names></name><name><surname>Roper</surname><given-names>D. I.</given-names></name><name><surname>Knox</surname><given-names>J. R.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name></person-group> (<year>2000</year>). <article-title>Vancomycin resistance in enterococci: reprogramming of the <sc>d</sc>-ala-<sc>d</sc>-ala ligases in bacterial peptidoglycan biosynthesis</article-title>. <source>Chem. Biol.</source>
<volume>7</volume>, <fpage>R109</fpage>&#x02013;<lpage>R119</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-5521(00)00116-2</pub-id>, PMID: <?supplied-pmid 10801476?><pub-id pub-id-type="pmid">10801476</pub-id></mixed-citation></ref><ref id="ref34"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>H. J.</given-names></name><name><surname>Hutchings</surname><given-names>M. I.</given-names></name><name><surname>Buttner</surname><given-names>M. J.</given-names></name></person-group> (<year>2008</year>). <article-title>Vancomycin resistance VanS/VanR two-component systems</article-title>. <source>Adv. Exp. Med. Biol.</source>
<volume>631</volume>, <fpage>200</fpage>&#x02013;<lpage>213</lpage>. <pub-id pub-id-type="doi">10.1007/978-0-387-78885-2_14</pub-id><pub-id pub-id-type="pmid">18792691</pub-id></mixed-citation></ref><ref id="ref35"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hong</surname><given-names>H. J.</given-names></name><name><surname>Hutchings</surname><given-names>M. I.</given-names></name><name><surname>Neu</surname><given-names>J. M.</given-names></name><name><surname>Wright</surname><given-names>G. D.</given-names></name><name><surname>Paget</surname><given-names>M. S. B.</given-names></name><name><surname>Buttner</surname><given-names>M. J.</given-names></name></person-group> (<year>2004</year>). <article-title>Characterization of an inducible vancomycin resistance system in <italic>Streptomyces coelicolor</italic> reveals a novel gene (vanK) required for drug resistance</article-title>. <source>Mol. Microbiol.</source>
<volume>52</volume>, <fpage>1107</fpage>&#x02013;<lpage>1121</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.2004.04032.x</pub-id>, PMID: <?supplied-pmid 15130128?><pub-id pub-id-type="pmid">15130128</pub-id></mixed-citation></ref><ref id="ref36"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname><given-names>J.</given-names></name><name><surname>Chen</surname><given-names>L.</given-names></name><name><surname>Li</surname><given-names>D.</given-names></name><name><surname>Wang</surname><given-names>M.</given-names></name><name><surname>Du</surname><given-names>F.</given-names></name><name><surname>Gao</surname><given-names>Y.</given-names></name><etal/></person-group>. (<year>2018</year>). <article-title>Emergence of a vanG-n carrying and multidrug resistant ICE in zoonotic pathogen <italic>Streptococcus suis</italic></article-title>. <source>Vet. Microbiol.</source>
<volume>222</volume>, <fpage>109</fpage>&#x02013;<lpage>113</lpage>. <pub-id pub-id-type="doi">10.1016/j.vetmic.2018.07.008</pub-id>, PMID: <?supplied-pmid 30080664?><pub-id pub-id-type="pmid">30080664</pub-id></mixed-citation></ref><ref id="ref37"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hugonnet</surname><given-names>J.-E.</given-names></name><name><surname>Haddache</surname><given-names>N.</given-names></name><name><surname>Veckerl&#x000e9;</surname><given-names>C.</given-names></name><name><surname>Dubost</surname><given-names>L.</given-names></name><name><surname>Marie</surname><given-names>A.</given-names></name><name><surname>Shikura</surname><given-names>N.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Peptidoglycan cross-linking in glycopeptide-resistant actinomycetales</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>58</volume>, <fpage>1749</fpage>&#x02013;<lpage>1756</lpage>. <pub-id pub-id-type="doi">10.1128/aac.02329-13</pub-id>, PMID: <?supplied-pmid 24395229?><pub-id pub-id-type="pmid">24395229</pub-id></mixed-citation></ref><ref id="ref38"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jeong</surname><given-names>H.</given-names></name><name><surname>Sim</surname><given-names>Y. M.</given-names></name><name><surname>Kim</surname><given-names>H. J.</given-names></name><name><surname>Lee</surname><given-names>D.-W.</given-names></name><name><surname>Lim</surname><given-names>S.-K.</given-names></name><name><surname>Lee</surname><given-names>S. J.</given-names></name></person-group> (<year>2013</year>). <article-title>Genome sequence of the vancomycin-producing <italic>Amycolatopsis orientalis</italic> subsp. <italic>orientalis</italic> strain KCTC 9412T</article-title>. <source>Genome Announc.</source>
<volume>1</volume>, <fpage>e00408</fpage>&#x02013;<lpage>e00413</lpage>. <pub-id pub-id-type="doi">10.1128/genomea.00408-13</pub-id>, PMID: <?supplied-pmid 23814036?><pub-id pub-id-type="pmid">23814036</pub-id></mixed-citation></ref><ref id="ref39"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaur</surname><given-names>N.</given-names></name><name><surname>Kumar</surname><given-names>S.</given-names></name><name><surname>Bala</surname><given-names>M.</given-names></name><name><surname>Raghava</surname><given-names>G. P. S.</given-names></name><name><surname>Mayilraj</surname><given-names>S.</given-names></name></person-group> (<year>2013</year>). <article-title>Draft genome sequence of <italic>Amycolatopsis decaplanina</italic> strain DSM 44594T</article-title>. <source>Genome Announc.</source>
<volume>1</volume>, <fpage>e00138</fpage>&#x02013;<lpage>e00113</lpage>. <pub-id pub-id-type="doi">10.1128/genomea.00138-13</pub-id>, PMID: <?supplied-pmid 23558534?><pub-id pub-id-type="pmid">23558534</pub-id></mixed-citation></ref><ref id="ref40"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kilian</surname><given-names>R.</given-names></name><name><surname>Frasch</surname><given-names>H.-J.</given-names></name><name><surname>Kulik</surname><given-names>A.</given-names></name><name><surname>Wohlleben</surname><given-names>W.</given-names></name><name><surname>Stegmann</surname><given-names>E.</given-names></name></person-group> (<year>2016</year>). <article-title>The VanRS homologous two-component system VnlRSAb of the glycopeptide producer <italic>Amycolatopsis balhimycina</italic> activates transcription of the vanHAXSc genes in <italic>Streptomyces coelicolor</italic>, but not in <italic>A. balhimycina</italic></article-title>. <source>Microb. Drug Resist.</source>
<volume>22</volume>, <fpage>499</fpage>&#x02013;<lpage>509</lpage>. <pub-id pub-id-type="doi">10.1089/mdr.2016.0128</pub-id>, PMID: <?supplied-pmid 27420548?><pub-id pub-id-type="pmid">27420548</pub-id></mixed-citation></ref><ref id="ref41"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Koteva</surname><given-names>K.</given-names></name><name><surname>Hong</surname><given-names>H.-J.</given-names></name><name><surname>Wang</surname><given-names>X. D.</given-names></name><name><surname>Nazi</surname><given-names>I.</given-names></name><name><surname>Hughes</surname><given-names>D.</given-names></name><name><surname>Naldrett</surname><given-names>M. J.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>A vancomycin photoprobe identifies the histidine kinase VanSsc as a vancomycin receptor</article-title>. <source>Nat. Chem. Biol.</source>
<volume>6</volume>, <fpage>327</fpage>&#x02013;<lpage>329</lpage>. <pub-id pub-id-type="doi">10.1038/nchembio.350</pub-id>, PMID: <?supplied-pmid 20383152?><pub-id pub-id-type="pmid">20383152</pub-id></mixed-citation></ref><ref id="ref42"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kunstmann</surname><given-names>M. P.</given-names></name><name><surname>Mitscher</surname><given-names>L. A.</given-names></name><name><surname>Porter</surname><given-names>J. N.</given-names></name><name><surname>Shay</surname><given-names>A. J.</given-names></name><name><surname>Darken</surname><given-names>M. A.</given-names></name></person-group> (<year>1968</year>). <article-title>LL-AV290, a new antibiotic. I. Fermentation, isolation, and characterization</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>8</volume>, <fpage>242</fpage>&#x02013;<lpage>245</lpage>. PMID: <?supplied-pmid 5735366?><pub-id pub-id-type="pmid">5735366</pub-id></mixed-citation></ref><ref id="ref43"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kwon</surname><given-names>Y.-J.</given-names></name><name><surname>Kim</surname><given-names>H.-J.</given-names></name><name><surname>Kim</surname><given-names>W.-G.</given-names></name></person-group> (<year>2015</year>). <article-title>Complestatin exerts antibacterial activity by the inhibition of fatty acid synthesis</article-title>. <source>Biol. Pharm. Bull.</source>
<volume>38</volume>, <fpage>715</fpage>&#x02013;<lpage>721</lpage>. <pub-id pub-id-type="doi">10.1248/bpb.b14-00824</pub-id>, PMID: <?supplied-pmid 25947917?><pub-id pub-id-type="pmid">25947917</pub-id></mixed-citation></ref><ref id="ref44"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Labeda</surname><given-names>D. P.</given-names></name></person-group> (<year>1995</year>). <article-title><italic>Amycolatopsis coloradensis</italic> sp., nov., the avoparcin (LL-AV290)-producing strain</article-title>. <source>Int. J. Syst. Evol. Microbiol.</source>
<volume>45</volume>, <fpage>124</fpage>&#x02013;<lpage>127</lpage>. <pub-id pub-id-type="doi">10.1099/00207713-45-1-124</pub-id></mixed-citation></ref><ref id="ref45"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Leclercq</surname><given-names>R.</given-names></name><name><surname>Derlot</surname><given-names>R.</given-names></name><name><surname>Duval</surname><given-names>E. J.</given-names></name><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group> (<year>1988</year>). <article-title>Plasmid-mediated resistance to vancomycin and teicoplanin in <italic>Enterococcus faecium</italic></article-title>. <source>N. Engl. J. Med.</source>
<volume>319</volume>, <fpage>157</fpage>&#x02013;<lpage>161</lpage>. <pub-id pub-id-type="doi">10.1056/NEJM198807213190307</pub-id>, PMID: <?supplied-pmid 2968517?><pub-id pub-id-type="pmid">2968517</pub-id></mixed-citation></ref><ref id="ref46"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lei</surname><given-names>X.</given-names></name><name><surname>Yuan</surname><given-names>F.</given-names></name><name><surname>Shi</surname><given-names>Y.</given-names></name><name><surname>Li</surname><given-names>X.</given-names></name><name><surname>Wang</surname><given-names>L.</given-names></name><name><surname>Hong</surname><given-names>B.</given-names></name></person-group> (<year>2015</year>). <article-title>Draft genome sequence of norvancomycin-producing strain <italic>Amycolatopsis orientalis</italic> CPCC200066</article-title>. <source>Genome Announc.</source>
<volume>3</volume>, <fpage>e00296</fpage>&#x02013;<lpage>e00215</lpage>. <pub-id pub-id-type="doi">10.1128/genomea.00296-15</pub-id>, PMID: <?supplied-pmid 25977416?><pub-id pub-id-type="pmid">25977416</pub-id></mixed-citation></ref><ref id="ref47"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>T.</given-names></name><name><surname>Huang</surname><given-names>F.</given-names></name><name><surname>Haydock</surname><given-names>S.</given-names></name><name><surname>Mironenko</surname><given-names>T.</given-names></name><name><surname>Leadlay</surname><given-names>P.</given-names></name><name><surname>Spencer</surname><given-names>J.</given-names></name></person-group> (<year>2004</year>). <article-title>Biosynthetic gene cluster of the glycopeptide antibiotic teicoplanin characterization of two glycosyltransferases and the key acyltransferase</article-title>. <source>Chem. Biol.</source>
<volume>11</volume>, <fpage>107</fpage>&#x02013;<lpage>119</lpage>. <pub-id pub-id-type="doi">10.1016/j.chembiol.2004.01.001</pub-id>, PMID: <?supplied-pmid 15113000?><pub-id pub-id-type="pmid">15113000</pub-id></mixed-citation></ref><ref id="ref48"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lo Grasso</surname><given-names>L.</given-names></name><name><surname>Maffioli</surname><given-names>S.</given-names></name><name><surname>Sosio</surname><given-names>M.</given-names></name><name><surname>Bibb</surname><given-names>M.</given-names></name><name><surname>Puglia</surname><given-names>A. M.</given-names></name><name><surname>Alduina</surname><given-names>R.</given-names></name></person-group> (<year>2015</year>). <article-title>Two master switch regulators trigger A40926 biosynthesis in <italic>Nonomuraea</italic> sp. strain ATCC 39727</article-title>. <source>J. Bacteriol.</source>
<volume>197</volume>, <fpage>2536</fpage>&#x02013;<lpage>2544</lpage>. <pub-id pub-id-type="doi">10.1128/JB.00262-15</pub-id>, PMID: <?supplied-pmid 25986904?><pub-id pub-id-type="pmid">25986904</pub-id></mixed-citation></ref><ref id="ref51"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcone</surname><given-names>G. L.</given-names></name><name><surname>Beltrametti</surname><given-names>F.</given-names></name><name><surname>Binda</surname><given-names>E.</given-names></name><name><surname>Carrano</surname><given-names>L.</given-names></name><name><surname>Foulston</surname><given-names>L.</given-names></name><name><surname>Hesketh</surname><given-names>A.</given-names></name><etal/></person-group>. (<year>2010</year>). <article-title>Novel mechanism of glycopeptide resistance in the A40926 producer <italic>Nonomuraea</italic> sp. ATCC 39727</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>54</volume>, <fpage>2465</fpage>&#x02013;<lpage>2472</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.00106-10</pub-id>, PMID: <?supplied-pmid 20308385?><pub-id pub-id-type="pmid">20308385</pub-id></mixed-citation></ref><ref id="ref49"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcone</surname><given-names>G. L.</given-names></name><name><surname>Binda</surname><given-names>E.</given-names></name><name><surname>Berini</surname><given-names>F.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name></person-group> (<year>2018</year>). <article-title>Old and new glycopeptide antibiotics: from product to gene and back in the post-genomic era</article-title>. <source>Biotechnol. Adv.</source>
<volume>36</volume>, <fpage>534</fpage>&#x02013;<lpage>554</lpage>. <pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.02.009</pub-id>, PMID: <?supplied-pmid 29454983?><pub-id pub-id-type="pmid">29454983</pub-id></mixed-citation></ref><ref id="ref50"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marcone</surname><given-names>G. L.</given-names></name><name><surname>Binda</surname><given-names>E.</given-names></name><name><surname>Carrano</surname><given-names>L.</given-names></name><name><surname>Bibb</surname><given-names>M.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name></person-group> (<year>2014</year>). <article-title>Relationship between glycopeptide production and resistance in the actinomycete <italic>Nonomuraea</italic> sp. ATCC 39727</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>58</volume>, <fpage>5191</fpage>&#x02013;<lpage>5201</lpage>. <pub-id pub-id-type="doi">10.1128/aac.02626-14</pub-id><pub-id pub-id-type="pmid">24957828</pub-id></mixed-citation></ref><ref id="ref52"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>C. G.</given-names></name><name><surname>Broadhead</surname><given-names>G.</given-names></name><name><surname>Leskiw</surname><given-names>B. K.</given-names></name><name><surname>Wright</surname><given-names>G. D.</given-names></name></person-group> (<year>1997</year>). <article-title><sc>d</sc>-Ala-<sc>d</sc>-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>94</volume>, <fpage>6480</fpage>&#x02013;<lpage>6483</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.94.12.6480</pub-id>, PMID: <?supplied-pmid 9177243?><pub-id pub-id-type="pmid">9177243</pub-id></mixed-citation></ref><ref id="ref53"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Marshall</surname><given-names>C. G.</given-names></name><name><surname>Lessard</surname><given-names>I. A. D.</given-names></name><name><surname>Park</surname><given-names>I.-S.</given-names></name><name><surname>Wright</surname><given-names>G. D.</given-names></name></person-group> (<year>1998</year>). <article-title>Glycopeptide antibiotic resistance genes in glycopeptide-producing organisms</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>42</volume>, <fpage>2215</fpage>&#x02013;<lpage>2220</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.42.9.2215</pub-id><pub-id pub-id-type="pmid">9736537</pub-id></mixed-citation></ref><ref id="ref54"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>W. R.</given-names></name><name><surname>Murray</surname><given-names>B. E.</given-names></name><name><surname>Rice</surname><given-names>L. B.</given-names></name><name><surname>Arias</surname><given-names>C. A.</given-names></name></person-group> (<year>2016</year>). <article-title>Vancomycin-resistant enterococci: therapeutic challenges in the 21st century</article-title>. <source>Infect. Dis. Clin. North Am.</source>
<volume>30</volume>, <fpage>415</fpage>&#x02013;<lpage>439</lpage>. <pub-id pub-id-type="doi">10.1016/j.idc.2016.02.006</pub-id>, PMID: <?supplied-pmid 27208766?><pub-id pub-id-type="pmid">27208766</pub-id></mixed-citation></ref><ref id="ref55"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nadkarni</surname><given-names>S. R.</given-names></name><name><surname>Patel</surname><given-names>M. V.</given-names></name><name><surname>Chatterjee</surname><given-names>S.</given-names></name><name><surname>Vijayakumar</surname><given-names>E. K. S.</given-names></name><name><surname>Desikan</surname><given-names>K. R.</given-names></name><name><surname>Blumbach</surname><given-names>J.</given-names></name><etal/></person-group>. (<year>1994</year>). <article-title>Balhimycin, a new glycopeptide antibiotic produced by <italic>Amycolatopsis</italic> sp. Y-86,21022. Taxonomy, production, isolation and biological activity</article-title>. <source>J. Antibiot.</source>
<volume>47</volume>, <fpage>334</fpage>&#x02013;<lpage>341</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.47.334</pub-id>, PMID: <?supplied-pmid 8175486?><pub-id pub-id-type="pmid">8175486</pub-id></mixed-citation></ref><ref id="ref56"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Naruse</surname><given-names>N.</given-names></name><name><surname>Oka</surname><given-names>M.</given-names></name><name><surname>Konishi</surname><given-names>M.</given-names></name><name><surname>Oki</surname><given-names>T.</given-names></name></person-group> (<year>1993</year>). <article-title>New antiviral antibiotics, Kistamicins A and B. II. Structure determination</article-title>. <source>J. Antibiot.</source>
<volume>46</volume>, <fpage>1812</fpage>&#x02013;<lpage>1818</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.46.1812</pub-id><pub-id pub-id-type="pmid">8294238</pub-id></mixed-citation></ref><ref id="ref57"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nazari</surname><given-names>B.</given-names></name><name><surname>Forneris</surname><given-names>C. C.</given-names></name><name><surname>Gibson</surname><given-names>M. I.</given-names></name><name><surname>Moon</surname><given-names>K.</given-names></name><name><surname>Schramma</surname><given-names>K. R.</given-names></name><name><surname>Seyedsayamdost</surname><given-names>M. R.</given-names></name></person-group> (<year>2017</year>). <article-title><italic>Nonomuraea</italic> sp. ATCC 55076 harbours the largest actinomycete chromosome to date and the kistamicin biosynthetic gene cluster</article-title>. <source>Med. Chem. Commun.</source>
<volume>8</volume>, <fpage>780</fpage>&#x02013;<lpage>788</lpage>. <pub-id pub-id-type="doi">10.1039/C6MD00637J</pub-id>, PMID: <?supplied-pmid 28626548?><pub-id pub-id-type="pmid">28626548</pub-id></mixed-citation></ref><ref id="ref58"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nicolaou</surname><given-names>K. C.</given-names></name><name><surname>Boddy</surname><given-names>C. N. C.</given-names></name><name><surname>Br&#x000e4;se</surname><given-names>S.</given-names></name><name><surname>Winssinger</surname><given-names>N.</given-names></name></person-group> (<year>1999</year>). <article-title>Chemistry, biology, and medicine of the glycopeptide antibiotics</article-title>. <source>Angew. Chem. Int. Ed. Engl.</source>
<volume>38</volume>, <fpage>2096</fpage>&#x02013;<lpage>2152</lpage>. <pub-id pub-id-type="doi">10.1002/(sici)1521-3773(19990802)38:15&#x0003c;2096::aid-anie2096&#x0003e;3.0.co;2-f</pub-id><pub-id pub-id-type="pmid">10425471</pub-id></mixed-citation></ref><ref id="ref59"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novotna</surname><given-names>G. B.</given-names></name><name><surname>Kwun</surname><given-names>M. J.</given-names></name><name><surname>Hong</surname><given-names>H.-J.</given-names></name></person-group> (<year>2016</year>). <article-title>In vivo characterization of the activation and interaction of the VanR-VanS two-component regulatory system controlling glycopeptide antibiotic resistance in two related <italic>Streptomyces</italic> species</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>60</volume>, <fpage>1627</fpage>&#x02013;<lpage>1637</lpage>. <pub-id pub-id-type="doi">10.1128/aac.01367-15</pub-id></mixed-citation></ref><ref id="ref60"><mixed-citation publication-type="other"><person-group person-group-type="editor"><name><surname>O&#x02019;Neill</surname><given-names>J.</given-names></name></person-group> (ed.). (<year>2016</year>). <source>Tackling drug-resistant infections globally: final report and recommendations. The review on antimicrobial resistance</source>. Available at: <email>http://amr-review.org/sites/default/files/160518_Final%20paper_with%20cover.pdf</email></mixed-citation></ref><ref id="ref61"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Patel</surname><given-names>R.</given-names></name><name><surname>Piper</surname><given-names>K.</given-names></name><name><surname>Cockerill</surname><given-names>F. R.</given-names></name><name><surname>Steckelberg</surname><given-names>J. M.</given-names></name><name><surname>Yousten</surname><given-names>A. A.</given-names></name></person-group> (<year>2000</year>). <article-title>The biopesticide <italic>Paenibacillus popilliae</italic> has a vancomycin resistance gene cluster homologous to the enterococcal VanA vancomycin resistance gene cluster</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>44</volume>, <fpage>705</fpage>&#x02013;<lpage>709</lpage>. <pub-id pub-id-type="doi">10.1128/aac.44.3.705-709.2000</pub-id>, PMID: <?supplied-pmid 10681342?><pub-id pub-id-type="pmid">10681342</pub-id></mixed-citation></ref><ref id="ref62"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Peltier</surname><given-names>J.</given-names></name><name><surname>Courtin</surname><given-names>P.</given-names></name><name><surname>Meouche</surname><given-names>E. I.</given-names></name><name><surname>Catel-Ferreira</surname><given-names>M.</given-names></name><name><surname>Chapot-Chartier</surname><given-names>M. P.</given-names></name><name><surname>Lem&#x000e9;e</surname><given-names>L.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Genomic and expression analysis of the vanG-like gene cluster of <italic>Clostridium difficile</italic></article-title>. <source>Microbiologica</source>
<volume>159</volume>, <fpage>1510</fpage>&#x02013;<lpage>1520</lpage>. <pub-id pub-id-type="doi">10.1099/mic.0.065060-0</pub-id>, PMID: <?supplied-pmid 23676437?><pub-id pub-id-type="pmid">23676437</pub-id></mixed-citation></ref><ref id="ref63"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perkins</surname><given-names>H. R.</given-names></name><name><surname>Nieto</surname><given-names>M.</given-names></name></person-group> (<year>1974</year>). <article-title>The chemical basis for the action of the vancomycin group of antibiotics</article-title>. <source>Ann. N. Y. Acad. Sci.</source>
<volume>235</volume>, <fpage>348</fpage>&#x02013;<lpage>363</lpage>. <pub-id pub-id-type="doi">10.1111/j.1749-6632.1974.tb43276.x</pub-id>, PMID: <?supplied-pmid 4369274?><pub-id pub-id-type="pmid">4369274</pub-id></mixed-citation></ref><ref id="ref64"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pootoolal</surname><given-names>J.</given-names></name><name><surname>Thomas</surname><given-names>M. G.</given-names></name><name><surname>Marshall</surname><given-names>C. G.</given-names></name><name><surname>Neu</surname><given-names>J. M.</given-names></name><name><surname>Hubbard</surname><given-names>B. K.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name><etal/></person-group>. (<year>2002</year>). <article-title>Assembling the glycopeptide antibiotic scaffold: the biosynthesis of from <italic>Streptomyces toyocaensis</italic> NRRL15009</article-title>. <source>Proc. Natl. Acad. Sci. U. S. A.</source>
<volume>99</volume>, <fpage>8962</fpage>&#x02013;<lpage>8967</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.102285099</pub-id>, PMID: <?supplied-pmid 12060705?><pub-id pub-id-type="pmid">12060705</pub-id></mixed-citation></ref><ref id="ref65"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Power</surname><given-names>E. G. M.</given-names></name><name><surname>Abdulla</surname><given-names>Y. H.</given-names></name><name><surname>Talsania</surname><given-names>H. G.</given-names></name><name><surname>Spice</surname><given-names>W.</given-names></name><name><surname>Aathithan</surname><given-names>S.</given-names></name><name><surname>French</surname><given-names>G. L.</given-names></name></person-group> (<year>1995</year>). <article-title>vanA genes in vancomycin-resistant clinical isolates of <italic>Oerskovia turbata</italic> and <italic>Arcanobacterium (Corynebacterium) haemolyticum</italic></article-title>. <source>J. Antimicrob. Chemother.</source>
<volume>36</volume>, <fpage>595</fpage>&#x02013;<lpage>606</lpage>. <pub-id pub-id-type="doi">10.1093/jac/36.4.595</pub-id>, PMID: <?supplied-pmid 8591934?><pub-id pub-id-type="pmid">8591934</pub-id></mixed-citation></ref><ref id="ref66"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Poyart</surname><given-names>C.</given-names></name><name><surname>Pierre</surname><given-names>C.</given-names></name><name><surname>Quesne</surname><given-names>G.</given-names></name><name><surname>Pron</surname><given-names>B.</given-names></name><name><surname>Berche</surname><given-names>P.</given-names></name><name><surname>Trieu-Cuot</surname><given-names>P.</given-names></name></person-group> (<year>1997</year>). <article-title>Emergence of vancomycin resistance in the genus <italic>Streptococcus</italic>: characterization of a vanB transferable determinant in <italic>Streptococcus bovis</italic></article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>41</volume>, <fpage>24</fpage>&#x02013;<lpage>29</lpage>. PMID: <?supplied-pmid 8980749?><pub-id pub-id-type="pmid">8980749</pub-id></mixed-citation></ref><ref id="ref67"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>P. E.</given-names></name><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group> (<year>2005</year>). <article-title>Vancomycin resistance in enterococci due to synthesis of precursors terminating in <sc>d</sc>-alanyl-<sc>d</sc>-serine</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>49</volume>, <fpage>21</fpage>&#x02013;<lpage>25</lpage>. <pub-id pub-id-type="doi">10.1128/AAC.49.1.21-25.2005</pub-id>, PMID: <?supplied-pmid 15616270?><pub-id pub-id-type="pmid">15616270</pub-id></mixed-citation></ref><ref id="ref68"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Reynolds</surname><given-names>P. E.</given-names></name><name><surname>Depardieu</surname><given-names>F.</given-names></name><name><surname>Dutka-Malen</surname><given-names>S.</given-names></name><name><surname>Arthur</surname><given-names>M.</given-names></name><name><surname>Courvalin</surname><given-names>P.</given-names></name></person-group> (<year>1994</year>). <article-title>Glycopeptide resistance mediated by enterococcal transposon <italic>Tn1546</italic> requires production of VanX for hydrolysis of <sc>d</sc>-alanyl-<sc>d</sc>-alanine</article-title>. <source>Mol. Microbiol.</source>
<volume>13</volume>, <fpage>1065</fpage>&#x02013;<lpage>1070</lpage>. <pub-id pub-id-type="doi">10.1111/j.1365-2958.1994.tb00497.x</pub-id>, PMID: <?supplied-pmid 7854121?><pub-id pub-id-type="pmid">7854121</pub-id></mixed-citation></ref><ref id="ref69"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sanchez</surname><given-names>M. L.</given-names></name><name><surname>Wenzel</surname><given-names>R. P.</given-names></name><name><surname>Jones</surname><given-names>R. N.</given-names></name></person-group> (<year>1992</year>). <article-title>In vitro activity of decaplanin (M86-1410), a new glycopeptide antibiotic</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>36</volume>, <fpage>873</fpage>&#x02013;<lpage>875</lpage>. <pub-id pub-id-type="doi">10.1128/aac.36.4.873</pub-id><pub-id pub-id-type="pmid">1386973</pub-id></mixed-citation></ref><ref id="ref70"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#x000e4;berle</surname><given-names>T. F.</given-names></name><name><surname>Vollmer</surname><given-names>W.</given-names></name><name><surname>Frasch</surname><given-names>H.-J.</given-names></name><name><surname>H&#x000fc;ttel</surname><given-names>S.</given-names></name><name><surname>Kulik</surname><given-names>A.</given-names></name><name><surname>R&#x000f6;ttgen</surname><given-names>M.</given-names></name><etal/></person-group>. (<year>2011</year>). <article-title>Self-resistance and cell wall composition in the glycopeptide producer <italic>Amycolatopsis balhimycina</italic></article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>55</volume>, <fpage>4283</fpage>&#x02013;<lpage>4289</lpage>. <pub-id pub-id-type="doi">10.1128/aac.01372-10</pub-id>, PMID: <?supplied-pmid 21690280?><pub-id pub-id-type="pmid">21690280</pub-id></mixed-citation></ref><ref id="ref71"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shawky</surname><given-names>R. M.</given-names></name><name><surname>Puk</surname><given-names>O.</given-names></name><name><surname>Wietzorrek</surname><given-names>A.</given-names></name><name><surname>Pelzer</surname><given-names>S.</given-names></name><name><surname>Takano</surname><given-names>E.</given-names></name><name><surname>Wohlleben</surname><given-names>W.</given-names></name><etal/></person-group>. (<year>2007</year>). <article-title>The border sequence of the balhimycin biosynthesis gene cluster from <italic>Amycolatopsis balhimycina</italic> contains <italic>bbr</italic>, encoding a StrR-like pathway-specific regulator</article-title>. <source>J. Mol. Microbiol. Biotechnol.</source>
<volume>13</volume>, <fpage>76</fpage>&#x02013;<lpage>88</lpage>. <pub-id pub-id-type="doi">10.1159/000103599</pub-id>, PMID: <?supplied-pmid 17693715?><pub-id pub-id-type="pmid">17693715</pub-id></mixed-citation></ref><ref id="ref72"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shearer</surname><given-names>M. C.</given-names></name><name><surname>Actor</surname><given-names>P.</given-names></name><name><surname>Bowie</surname><given-names>B. A.</given-names></name><name><surname>Grappel</surname><given-names>S. F.</given-names></name><name><surname>Nash</surname><given-names>C. H.</given-names></name><name><surname>Newman</surname><given-names>D. J.</given-names></name><etal/></person-group>. (<year>1985</year>). <article-title>Aridicins, novel glycopeptide antibiotics. I. Taxonomy, production and biological activity</article-title>. <source>J. Antibiot.</source>
<volume>38</volume>, <fpage>555</fpage>&#x02013;<lpage>560</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.38.555</pub-id>, PMID: <?supplied-pmid 4019307?><pub-id pub-id-type="pmid">4019307</pub-id></mixed-citation></ref><ref id="ref73"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shearer</surname><given-names>M. C.</given-names></name><name><surname>Giovenella</surname><given-names>A. J.</given-names></name><name><surname>Grappel</surname><given-names>S. F.</given-names></name><name><surname>Hedde</surname><given-names>R. D.</given-names></name><name><surname>Mehta</surname><given-names>R. J.</given-names></name><name><surname>Oh</surname><given-names>Y. K.</given-names></name><etal/></person-group>. (<year>1986</year>). <article-title>Kibdelins, novel glycopeptide antibiotics. I. Discovery, production, and biological evaluation</article-title>. <source>J. Antibiot.</source>
<volume>39</volume>, <fpage>1386</fpage>&#x02013;<lpage>1394</lpage>. <pub-id pub-id-type="doi">10.7164/antibiotics.39.1386</pub-id>, PMID: <?supplied-pmid 3781909?><pub-id pub-id-type="pmid">3781909</pub-id></mixed-citation></ref><ref id="ref74"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Skelton</surname><given-names>N. J.</given-names></name><name><surname>Williams</surname><given-names>D. H.</given-names></name><name><surname>Monday</surname><given-names>R. A.</given-names></name><name><surname>Ruddock</surname><given-names>J. C.</given-names></name></person-group> (<year>1990</year>). <article-title>Structure elucidation of the novel glycopeptide antibiotic UK-68,597</article-title>. <source>J. Org. Chem. Res.</source>
<volume>55</volume>, <fpage>3718</fpage>&#x02013;<lpage>3723</lpage>. <pub-id pub-id-type="doi">10.1021/jo00299a008</pub-id></mixed-citation></ref><ref id="ref75"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sosio</surname><given-names>M.</given-names></name><name><surname>Stinchi</surname><given-names>S.</given-names></name><name><surname>Beltrametti</surname><given-names>F.</given-names></name><name><surname>Lazzarini</surname><given-names>A.</given-names></name><name><surname>Donadio</surname><given-names>S.</given-names></name></person-group> (<year>2003</year>). <article-title>The gene cluster for the biosynthesis of the glycopeptide antibiotic A40926 by <italic>Nonomuraea</italic> species</article-title>. <source>Chem. Biol.</source>
<volume>10</volume>, <fpage>541</fpage>&#x02013;<lpage>549</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-5521(03)00120-0</pub-id>, PMID: <?supplied-pmid 12837387?><pub-id pub-id-type="pmid">12837387</pub-id></mixed-citation></ref><ref id="ref76"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Spohn</surname><given-names>M.</given-names></name><name><surname>Kirchner</surname><given-names>N.</given-names></name><name><surname>Kulik</surname><given-names>A.</given-names></name><name><surname>Jochim</surname><given-names>A.</given-names></name><name><surname>Wolf</surname><given-names>F.</given-names></name><name><surname>Muenzer</surname><given-names>P.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Overproduction of ristomycin A by activation of a silent gene cluster in <italic>Amycolatopsis japonicum</italic> MG417-CF17</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>58</volume>, <fpage>6185</fpage>&#x02013;<lpage>6196</lpage>. <pub-id pub-id-type="doi">10.1128/aac.03512-14</pub-id>, PMID: <?supplied-pmid 25114137?><pub-id pub-id-type="pmid">25114137</pub-id></mixed-citation></ref><ref id="ref77"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Thaker</surname><given-names>M. N.</given-names></name><name><surname>Wang</surname><given-names>W.</given-names></name><name><surname>Spanogiannopoulos</surname><given-names>P.</given-names></name><name><surname>Waglechner</surname><given-names>N.</given-names></name><name><surname>King</surname><given-names>A. M.</given-names></name><name><surname>Medina</surname><given-names>R.</given-names></name><etal/></person-group>. (<year>2013</year>). <article-title>Identifying producers of antibacterial compounds by screening for antibiotic resistance</article-title>. <source>Nat. Biotechnol.</source>
<volume>31</volume>, <fpage>922</fpage>&#x02013;<lpage>927</lpage>. <pub-id pub-id-type="doi">10.1038/nbt.2685</pub-id>, PMID: <?supplied-pmid 24056948?><pub-id pub-id-type="pmid">24056948</pub-id></mixed-citation></ref><ref id="ref78"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Truman</surname><given-names>A. W.</given-names></name><name><surname>Kwun</surname><given-names>M. J.</given-names></name><name><surname>Cheng</surname><given-names>J.</given-names></name><name><surname>Yang</surname><given-names>S. H.</given-names></name><name><surname>Suh</surname><given-names>J.-W.</given-names></name><name><surname>Hong</surname><given-names>H.-J.</given-names></name></person-group> (<year>2014</year>). <article-title>Antibiotic resistance mechanisms inform discovery: identification and characterization of a novel <italic>Amycolatopsis</italic> strain producing ristocetin</article-title>. <source>Antimicrob. Agents Chemother.</source>
<volume>58</volume>, <fpage>5687</fpage>&#x02013;<lpage>5695</lpage>. <pub-id pub-id-type="doi">10.1128/aac.03349-14</pub-id><pub-id pub-id-type="pmid">25022591</pub-id></mixed-citation></ref><ref id="ref80"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Vehreschild</surname><given-names>M. J. G. T.</given-names></name><name><surname>Haverkamp</surname><given-names>M.</given-names></name><name><surname>Biehl</surname><given-names>L. M.</given-names></name><name><surname>Lemmen</surname><given-names>S.</given-names></name><name><surname>F&#x000e4;tkenheuer</surname><given-names>G.</given-names></name></person-group> (<year>2019</year>). <article-title>Vancomycin-resistant enterococci (VRE): a reason to isolate?</article-title>
<source>Infection</source>
<volume>47</volume>, <fpage>7</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1007/s15010-018-1202-9</pub-id>, PMID: <?supplied-pmid 30178076?><pub-id pub-id-type="pmid">30178076</pub-id></mixed-citation></ref><ref id="ref79"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>van Wageningen</surname><given-names>A. V.</given-names></name><name><surname>Kirkpatrick</surname><given-names>P. N.</given-names></name><name><surname>Williams</surname><given-names>D. H.</given-names></name><name><surname>Harris</surname><given-names>B. R.</given-names></name><name><surname>Kershaw</surname><given-names>J. K.</given-names></name><name><surname>Lennard</surname><given-names>N. J.</given-names></name><etal/></person-group>. (<year>1998</year>). <article-title>Sequencing and analysis of genes involved in the biosynthesis of a vancomycin group antibiotic</article-title>. <source>Chem. Biol.</source>
<volume>5</volume>, <fpage>155</fpage>&#x02013;<lpage>162</lpage>. <pub-id pub-id-type="doi">10.1016/S1074-5521(98)90060-6</pub-id>, PMID: <?supplied-pmid 9545426?><pub-id pub-id-type="pmid">9545426</pub-id></mixed-citation></ref><ref id="ref81"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waglechner</surname><given-names>N.</given-names></name><name><surname>McArthur</surname><given-names>A. G.</given-names></name><name><surname>Wright</surname><given-names>G. D.</given-names></name></person-group> (<year>2019</year>). <article-title>Phylogenetic reconciliation reveals the natural history of glycopeptide antibiotic biosynthesis and resistance</article-title>. <source>Nat. Microbiol.</source>
<volume>4</volume>, <fpage>1862</fpage>&#x02013;<lpage>1871</lpage>. <pub-id pub-id-type="doi">10.1038/s41564-019-0531-5</pub-id>, PMID: <?supplied-pmid 31406334?><pub-id pub-id-type="pmid">31406334</pub-id></mixed-citation></ref><ref id="ref82"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weigel</surname><given-names>L. M.</given-names></name><name><surname>Clewell</surname><given-names>D. B.</given-names></name><name><surname>Gill</surname><given-names>S. R.</given-names></name><name><surname>Clark</surname><given-names>N. C.</given-names></name><name><surname>McDougal</surname><given-names>L. K.</given-names></name><name><surname>Flannagan</surname><given-names>S. E.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>Genetic analysis of a high-level vancomycin-resistant isolate of <italic>Staphylococcus aureus</italic></article-title>. <source>Science</source>
<volume>302</volume>, <fpage>1569</fpage>&#x02013;<lpage>1571</lpage>. <pub-id pub-id-type="doi">10.1126/science.1090956</pub-id>, PMID: <?supplied-pmid 14645850?><pub-id pub-id-type="pmid">14645850</pub-id></mixed-citation></ref><ref id="ref83"><mixed-citation publication-type="other"><person-group person-group-type="author"><collab id="coll1">WHO</collab></person-group> (<year>2017</year>). Antibacterial agents in clinical development: an analysis of the antibacterial clinical development pipeline, including tuberculosis. World Health Organization. WHO/EMP/IAU/2017.11</mixed-citation></ref><ref id="ref84"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wink</surname><given-names>J. M.</given-names></name><name><surname>Kroppenstedt</surname><given-names>R. M.</given-names></name><name><surname>Ganguli</surname><given-names>B. N.</given-names></name><name><surname>Nadkarni</surname><given-names>S. R.</given-names></name><name><surname>Schumann</surname><given-names>P.</given-names></name><name><surname>Seibert</surname><given-names>G.</given-names></name><etal/></person-group>. (<year>2003</year>). <article-title>Three new antibiotic producing species of the genus <italic>Amycolatopsis</italic>, <italic>Amycolatopsis balhimycina</italic> sp. nov., <italic>A. tolypomycina</italic> sp. nov., <italic>A. vancoresmycina</italic> sp. nov., and description of <italic>Amycolatopsis keratiniphila</italic> subsp. <italic>keratiniphila</italic> subsp. nov. and <italic>A. keratiniphila</italic> subsp. <italic>nogabecina</italic> subsp. nov</article-title>. <source>Syst. Appl. Microbiol.</source>
<volume>26</volume>, <fpage>38</fpage>&#x02013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1078/072320203322337290</pub-id>, PMID: <?supplied-pmid 12747408?><pub-id pub-id-type="pmid">12747408</pub-id></mixed-citation></ref><ref id="ref85"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wright</surname><given-names>G. D.</given-names></name><name><surname>Holman</surname><given-names>T. R.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name></person-group> (<year>1993</year>). <article-title>Purification and characterization of VanR and the cytosolic domain of VanS: a two-component regulatory system required for vancomycin resistance in <italic>Enterococcus faecium</italic> BM4147</article-title>. <source>Biochemist</source>
<volume>32</volume>, <fpage>5057</fpage>&#x02013;<lpage>5063</lpage>. <pub-id pub-id-type="doi">10.1021/bi00070a013</pub-id>, PMID: <?supplied-pmid 8494882?><pub-id pub-id-type="pmid">8494882</pub-id></mixed-citation></ref><ref id="ref86"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>Z.</given-names></name><name><surname>Wright</surname><given-names>G. D.</given-names></name><name><surname>Walsh</surname><given-names>C. T.</given-names></name></person-group> (<year>1995</year>). <article-title>Overexpression, purification, and characterization of VanX, a <sc>d</sc>,<sc>d</sc>-dipeptidase which is essential for vancomycin resistance in <italic>Enterococcus faecium</italic> BM4147</article-title>. <source>Biochemist</source>
<volume>34</volume>, <fpage>2455</fpage>&#x02013;<lpage>2463</lpage>. <pub-id pub-id-type="doi">10.1021/bi00008a008</pub-id>, PMID: <?supplied-pmid 7873524?><pub-id pub-id-type="pmid">7873524</pub-id></mixed-citation></ref><ref id="ref87"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Xu</surname><given-names>L.</given-names></name><name><surname>Huang</surname><given-names>H.</given-names></name><name><surname>Wei</surname><given-names>W.</given-names></name><name><surname>Zhong</surname><given-names>Y.</given-names></name><name><surname>Tang</surname><given-names>B.</given-names></name><name><surname>Yuan</surname><given-names>H.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Complete genome sequence and comparative genomic analyses of the vancomycin-producing <italic>Amycolatopsis orientalis</italic></article-title>. <source>BMC Genomics</source>
<volume>15</volume>:<fpage>363</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2164-15-363</pub-id>, PMID: <?supplied-pmid 24884615?><pub-id pub-id-type="pmid">24884615</pub-id></mixed-citation></ref><ref id="ref88"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yim</surname><given-names>G.</given-names></name><name><surname>Kalan</surname><given-names>L.</given-names></name><name><surname>Koteva</surname><given-names>K.</given-names></name><name><surname>Thaker</surname><given-names>M. N.</given-names></name><name><surname>Waglechner</surname><given-names>N.</given-names></name><name><surname>Tang</surname><given-names>I.</given-names></name><etal/></person-group>. (<year>2014</year>). <article-title>Harnessing the synthetic capabilities of glycopeptide antibiotic tailoring enzymes: characterization of the UK-68,597 biosynthetic cluster</article-title>. <source>Chembiochem</source>
<volume>15</volume>, <fpage>2613</fpage>&#x02013;<lpage>2623</lpage>. <pub-id pub-id-type="doi">10.1002/cbic.201402179</pub-id>, PMID: <?supplied-pmid 25255985?><pub-id pub-id-type="pmid">25255985</pub-id></mixed-citation></ref><ref id="ref90"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yushchuk</surname><given-names>O.</given-names></name><name><surname>Homoniuk</surname><given-names>V.</given-names></name><name><surname>Ostash</surname><given-names>B.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name><name><surname>Fedorenko</surname><given-names>V.</given-names></name></person-group> (<year>2020b</year>). <article-title>Genetic insights into the mechanism of teicoplanin self-resistance in <italic>Actinoplanes teichomyceticus</italic></article-title>. <source>J. Antibiot.</source>
<volume>73</volume>, <fpage>255</fpage>&#x02013;<lpage>259</lpage>. <pub-id pub-id-type="doi">10.1038/s41429-019-0274-9</pub-id><pub-id pub-id-type="pmid">31953525</pub-id></mixed-citation></ref><ref id="ref91"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yushchuk</surname><given-names>O.</given-names></name><name><surname>Horbal</surname><given-names>L.</given-names></name><name><surname>Ostash</surname><given-names>B.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name><name><surname>Wohlleben</surname><given-names>W.</given-names></name><name><surname>Stegmann</surname><given-names>E.</given-names></name><etal/></person-group>. (<year>2019</year>). <article-title>Regulation of teicoplanin biosynthesis: refining the roles of <italic>tei</italic> cluster-situated regulatory genes</article-title>. <source>Appl. Microbiol. Biotechnol.</source>
<volume>103</volume>, <fpage>4089</fpage>&#x02013;<lpage>4102</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-019-09789-w</pub-id>, PMID: <?supplied-pmid 30937499?><pub-id pub-id-type="pmid">30937499</pub-id></mixed-citation></ref><ref id="ref89"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yushchuk</surname><given-names>O.</given-names></name><name><surname>Ostash</surname><given-names>B.</given-names></name><name><surname>Truman</surname><given-names>A. W.</given-names></name><name><surname>Marinelli</surname><given-names>F.</given-names></name><name><surname>Fedorenko</surname><given-names>V.</given-names></name></person-group> (<year>2020a</year>). <article-title>Teicoplanin biosynthesis: unraveling the interplay of structural, regulatory, and resistance genes</article-title>. <source>Appl. Microbiol. Biotechnol.</source>
<volume>104</volume>, <fpage>3279</fpage>&#x02013;<lpage>3291</lpage>. <pub-id pub-id-type="doi">10.1007/s00253-020-10436-y</pub-id><pub-id pub-id-type="pmid">32076781</pub-id></mixed-citation></ref><ref id="ref92"><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname><given-names>D.</given-names></name><name><surname>Debabov</surname><given-names>D.</given-names></name><name><surname>Hartsell</surname><given-names>T. L.</given-names></name><name><surname>Cano</surname><given-names>R. J.</given-names></name><name><surname>Adams</surname><given-names>S.</given-names></name><name><surname>Schuyler</surname><given-names>J. A.</given-names></name><etal/></person-group> (<year>2016</year>). <article-title>Approved glycopeptide antibacterial drugs: mechanism of action and resistance</article-title>. <source>Cold Spring Harb. Perspect. Med.</source>
<volume>6</volume>:<fpage>a026989</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a026989</pub-id><pub-id pub-id-type="pmid">27663982</pub-id></mixed-citation></ref></ref-list></back></article>